pmid|annotator|subject_text_span|subject_label|predicate|object_text_span|object_label
35654142|expert_3|PD symptoms|DDF|target|mice|animal
32816830|expert_3|IBS|DDF|target|patients|human
32816830|expert_3|IBS|DDF|target|people|human
32816830|expert_3|irritable bowel syndrome|DDF|target|people|human
30659564|expert_7|gut microbiome|microbiome|is linked to|inflammatory gastrointestinal disorders|DDF
30659564|expert_7|gut microbiota|microbiome|is linked to|chronic stress|DDF
30659564|expert_7|gut microbiome|microbiome|is linked to|obesity|DDF
30659564|expert_7|gut microbiota|microbiome|is linked to|mental disorders|DDF
30659564|expert_7|gut microbiota|microbiome|is linked to|depression|DDF
30659564|expert_7|gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
38283894|expert_5|autism spectrum disorders|DDF|target|adolescents|human
38283894|expert_5|Parabacteroides|bacteria|located in|controls|human
38283894|expert_5|oxytocin|chemical|located in|controls|human
38283894|expert_5|CRP|chemical|located in|Children|human
38283894|expert_5|Faecalibacterium|bacteria|located in|Children|human
38283894|expert_5|Parabacteroides|bacteria|located in|children|human
38283894|expert_5|Bifidobacterium|bacteria|located in|Children|human
38283894|expert_5|ASD|DDF|target|Children|human
38283894|expert_5|Autism spectrum disorder|DDF|target|children|human
38283894|expert_5|oxytocin|chemical|located in|children|human
38283894|expert_5|Bacteroides|bacteria|located in|Children|human
38283894|expert_5|iron|chemical|located in|Children|human
38283894|expert_5|Faecalibacterium|bacteria|located in|controls|human
38283894|expert_5|Bifidobacterium|bacteria|located in|controls|human
38283894|expert_5|iron|chemical|located in|children|human
38283894|expert_5|CRP|chemical|located in|controls|human
38283894|expert_5|CRP|chemical|located in|children|human
38283894|expert_5|Bacteroides|bacteria|located in|controls|human
38283894|expert_5|ASD|DDF|target|children|human
38283894|expert_5|iron|chemical|located in|controls|human
38283894|expert_5|Clostridium|bacteria|located in|Children|human
38283894|expert_5|Bifidobacterium|bacteria|located in|children|human
38283894|expert_5|trace elements|chemical|located in|children|human
38283894|expert_5|Autism spectrum disorder|DDF|target|adolescents|human
38283894|expert_5|autism spectrum disorder|DDF|target|children|human
38283894|expert_5|Bacteroides|bacteria|located in|children|human
38283894|expert_5|zinc|chemical|located in|Children|human
38283894|expert_5|zinc|chemical|located in|controls|human
38283894|expert_5|Clostridium|bacteria|located in|controls|human
38283894|expert_5|trace elements|chemical|located in|control subjects|human
38283894|expert_5|trace elements|chemical|located in|adolescents|human
38283894|expert_5|trace elements|chemical|located in|healthy controls|human
38283894|expert_5|Clostridium|bacteria|located in|children|human
38283894|expert_5|ASD|DDF|target|adolescents|human
38283894|expert_5|autism spectrum disorders|DDF|target|children|human
38283894|expert_5|zinc|chemical|located in|children|human
38283894|expert_5|GABA|chemical|located in|children|human
38283894|expert_5|GABA|chemical|located in|Children|human
38283894|expert_5|Parabacteroides|bacteria|located in|Children|human
38283894|expert_5|GABA|chemical|located in|controls|human
38283894|expert_5|oxytocin|chemical|located in|Children|human
38283894|expert_5|c-reactive protein|chemical|located in|children|human
36072680|expert_6|gut microbiota|microbiome|is linked to|gastroenteritis|DDF
36072680|expert_6|gut microbiota|microbiome|is linked to|stress|DDF
36072680|expert_6|Irritable bowel syndrome|DDF|is a|chronic debilitating issues|DDF
36072680|expert_6|IBS|DDF|target|patients|human
36072680|expert_6|IBS|DDF|is a|chronic debilitating issues|DDF
37127945|expert_4|BD|DDF|target|patients|human
37127945|expert_4|BD|DDF|change abundance|Ruminococcus|bacteria
37127945|expert_4|BD|DDF|change abundance|Lactobacillus|bacteria
37127945|expert_4|Probiotic supplementation|dietary supplement|influence|cognitive impairments|DDF
37127945|expert_4|BD|DDF|change abundance|Faecalibacterium|bacteria
37127945|expert_4|depressive symptoms|DDF|target|patients|human
37127945|expert_4|Probiotic supplementation|dietary supplement|influence|depressive symptoms|DDF
37127945|expert_4|cognitive impairments|DDF|target|patients|human
36411639|expert_4|Gut microbes|bacteria|influence|irritable bowel syndrome|DDF
36411639|expert_4|Gut microbial-derived metabolites|chemical|influence|neurological diseases|DDF
36411639|expert_4|Gut microbes|bacteria|influence|ulcer stomach and intestine|DDF
36411639|expert_4|Gut microbes|bacteria|influence|gastrointestinal diseases|DDF
36411639|expert_4|Gut microbial-derived metabolites|chemical|influence|Alzheimer's disease|DDF
36411639|expert_4|Gut microbial-derived metabolites|chemical|influence|Parkinson's disease|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|multiple sclerosis|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|neurological disorders|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|atherosclerosis|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|Alzheimer's disease|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|inflammatory bowel diseases|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|rheumatoid arthritis|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|ischemic and non-ischemic heart disease|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|inflammatory issues|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|neurologic disorders|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|amyotrophic lateral sclerosis|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|obesity|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|Parkinson's disease|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|liver diseases|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|cardiovascular diseases|DDF
32545788|expert_6|dead cells|chemical|influence|Inflammation|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|metabolic pathologies|DDF
32545788|expert_6|pathogens|chemical|influence|Inflammation|DDF
32545788|expert_6|NLRP3 inflammasome|chemical|influence|type 2 diabetes|DDF
32545788|expert_6|irritants|chemical|influence|Inflammation|DDF
30072879|expert_2|group III mGlu|chemical|interact|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical
30072879|expert_2|gastrointestinal dysfunction|DDF|affect|Parkinson's disease|DDF
30072879|expert_2|mGlu8|chemical|interact|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical
30072879|expert_2|mGlu8|chemical|interact|MPTP|chemical
30072879|expert_2|MPTP|chemical|impact|gut microbiome|microbiome
30072879|expert_2|gut microbiome|microbiome|located in|WT and KO mice|animal
30072879|expert_2|gut microbiome|microbiome|is linked to|PD pathogenesis|DDF
30072879|expert_2|mGlu8|chemical|influence|PD|DDF
30072879|expert_2|Motor dysfunction|DDF|affect|Parkinson's disease|DDF
30072879|expert_2|metabotropic glutamate receptor 8|chemical|interact|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical
30072879|expert_2|group III mGlu|chemical|interact|MPTP|chemical
30072879|expert_2|1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine|chemical|impact|gut microbiome|microbiome
30072879|expert_2|Parkinson's disease|DDF|target|female and male mice|animal
30072879|expert_2|Motor dysfunction|DDF|affect|PD|DDF
30072879|expert_2|metabotropic glutamate receptor 8|chemical|interact|MPTP|chemical
30072879|expert_2|gastrointestinal dysfunction|DDF|affect|PD|DDF
32572814|expert_4|AR 420626|drug|interact|FA3R|chemical
32572814|expert_4|BHB|drug|interact|butyrate|chemical
32572814|expert_4|BHB|drug|interact|SALS|chemical
32572814|expert_4|Butyrate|chemical|influence|Salsolinol-Induced Toxicity|DDF
32572814|expert_4|Butyrate|chemical|located in|gut|anatomical location
32572814|expert_4|BHB|drug|interact|FA3R|chemical
32572814|expert_4|AR 420626|drug|interact|SALS|chemical
32572814|expert_4|beta-hydroxy butyrate|drug|interact|butyrate|chemical
32572814|expert_4|beta-hydroxy butyrate|drug|interact|FA3R|chemical
30828318|expert_5|gut microbiota|microbiome|located in|agile, fit hunter gatherers|human
30828318|expert_5|probiotic applications|dietary supplement|influence|depression|DDF
30828318|expert_5|gut|anatomical location|located in|obese westerners|human
30828318|expert_5|gut|anatomical location|located in|agile, fit hunter gatherers|human
30828318|expert_5|gut microbiota|microbiome|located in|Danes|human
30828318|expert_5|gut microbiota|microbiome|located in|obese westerners|human
30828318|expert_5|gut microbiota|microbiome|located in|gut|anatomical location
30828318|expert_5|gut microbiota|microbiome|located in|brain|anatomical location
30828318|expert_5|gut|anatomical location|located in|Danes|human
30828318|expert_5|probiotic applications|dietary supplement|influence|anxiety|DDF
31148353|expert_5|L-3,4-dihydroxyphenylalanine (L-DOPA)|drug|change effect|PD|DDF
31148353|expert_5|hUCB-derived plasma|chemical|located in|SNpc|anatomical location
31148353|expert_5|L-3,4-dihydroxyphenylalanine (L-DOPA)|drug|change effect|Parkinson's disease|DDF
31148353|expert_5|inflammation-associated gut microbiota|microbiome|located in|gut|anatomical location
31148353|expert_5|anti-inflammatory cytokines|chemical|influence|parkinsonian symptoms|DDF
31148353|expert_5|pro-inflammatory cytokines|chemical|located in|SNpc|anatomical location
31148353|expert_5|hUCB-derived plasma|chemical|located in|substantia nigra pars compacta|anatomical location
31148353|expert_5|gut microbiome|microbiome|is linked to|PD|DDF
31148353|expert_5|parkinsonian symptoms|DDF|affect|PD|DDF
31148353|expert_5|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
31148353|expert_5|parkinsonian symptoms|DDF|affect|Parkinson's disease|DDF
31148353|expert_5|gut microbiome|microbiome|located in|gut|anatomical location
31148353|expert_5|L-3,4-dihydroxyphenylalanine (L-DOPA)|drug|change effect|dyskinetic side effects|DDF
31821833|expert_5|gut microbiota|microbiome|is linked to|schizophrenia|DDF
31821833|expert_5|human microbiome|microbiome|is linked to|CNS diseases|DDF
31821833|expert_5|gastrointestinal microbiota|microbiome|located in|gut|anatomical location
31821833|expert_5|gut microbiota|microbiome|is linked to|CNS diseases|DDF
31821833|expert_5|intestinal microbiota|microbiome|located in|gut|anatomical location
31821833|expert_5|intestinal microbiota|microbiome|is linked to|CNS diseases|DDF
31821833|expert_5|gastrointestinal microbiota|microbiome|is linked to|schizophrenia|DDF
31821833|expert_5|gastrointestinal microbiota|microbiome|is linked to|CNS diseases|DDF
31821833|expert_5|human microbiome|microbiome|is linked to|schizophrenia|DDF
31821833|expert_5|intestinal microbiota|microbiome|is linked to|schizophrenia|DDF
31821833|expert_5|gut microbiota|microbiome|located in|gut|anatomical location
33063712|expert_4|cancer|DDF|change abundance|gut microbiota|microbiome
33063712|expert_4|neurodegenerative disorders|DDF|change abundance|gut microbiota|microbiome
33063712|expert_4|human disorders|DDF|change abundance|gut microbiota|microbiome
36462169|expert_4|SMI|DDF|interact|sMAdCAM-1|chemical
36462169|expert_4|SMI|DDF|interact|LBP|chemical
36462169|expert_4|SCZ|DDF|interact|CCL25|chemical
36462169|expert_4|AFF|DDF|interact|I-FABP|chemical
36462169|expert_4|SMI|DDF|interact|CCL25|chemical
36462169|expert_4|SMI|DDF|interact|I-FABP|chemical
36462169|expert_4|I-FABP|chemical|interact|IL-18BPa|chemical
36462169|expert_4|AFF|DDF|interact|LBP|chemical
27698624|expert_2|gut microbiota|microbiome|is linked to|depression|DDF
27698624|expert_2|gut microbiota|microbiome|is linked to|anxiety|DDF
27698624|expert_2|gut microbiota|microbiome|is linked to|stress related disorders|DDF
27698624|expert_2|Gut Microbiome|microbiome|is linked to|Anxiety|DDF
33938181|expert_5|multidrug resistant bacteria|bacteria|interact|human glucose-dependent insulinotropic polypeptide|chemical
33938181|expert_5|Increasing antibiotic resistance|DDF|change abundance|Gram-negative bacteria|bacteria
33938181|expert_5|gastrointestinal peptides|chemical|impact|gut microbiota|microbiome
33938181|expert_5|E. amylovora 1189|bacteria|interact|multidrug resistant bacteria|bacteria
33938181|expert_5|multidrug resistant bacteria|bacteria|interact|GIP|chemical
33938181|expert_5|TolC|chemical|part of|inner and outer membrane efflux pump factor proteins|chemical
33938181|expert_5|E. coli TG1|bacteria|interact|multidrug resistant bacteria|bacteria
33938181|expert_5|Human glucose-dependent insulinotropic polypeptide|chemical|impact|antimicrobial adjuvant re-sensitising multidrug-resistant Gram-negative bacteria|bacteria
33938181|expert_5|GIP|chemical|impact|antimicrobial adjuvant re-sensitising multidrug-resistant Gram-negative bacteria|bacteria
33938181|expert_5|AcrB|chemical|part of|inner and outer membrane efflux pump factor proteins|chemical
31917834|expert_2|stress|DDF|affect|dysbiosis|DDF
31917834|expert_2|Adolescence Inflammatory Stress|DDF|affect|Neurodegeneration|DDF
31917834|expert_2|gut microbiota|microbiome|is linked to|stress|DDF
31917834|expert_2|depression|DDF|is a|neurological disorders|DDF
31917834|expert_2|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
31917834|expert_2|Alzheimer's disease|DDF|is a|neurological disorders|DDF
31917834|expert_2|probiotics|dietary supplement|influence|dysbiosis|DDF
31917834|expert_2|probiotics|dietary supplement|influence|brain disorders|DDF
31917834|expert_2|pubertal neuroinflammatory insults|DDF|affect|brain disorders|DDF
31917834|expert_2|neuroinflammation|DDF|affect|dysbiosis|DDF
31917834|expert_2|dysbiosis|DDF|affect|brain disorders|DDF
31917834|expert_2|probiotics|dietary supplement|influence|inflammation|DDF
31917834|expert_2|infection|DDF|affect|dysbiosis|DDF
31917834|expert_2|Microbiota Alterations|DDF|affect|Neurodegeneration|DDF
31917834|expert_2|Parkinson's disease|DDF|is a|neurological disorders|DDF
38123016|expert_2|ASD|DDF|is a|neurodevelopmental disorders|DDF
38123016|expert_2|metabolite supplementation|dietary supplement|influence|ASD|DDF
38123016|expert_2|gut microbiota|microbiome|located in|ASD patients|human
38123016|expert_2|probiotics|dietary supplement|influence|ASD|DDF
38123016|expert_2|microbiota modulators|dietary supplement|influence|ASD|DDF
38123016|expert_2|autism spectrum disorder|DDF|is a|neurodevelopmental disorders|DDF
38123016|expert_2|infections|DDF|change abundance|gut microbiome|microbiome
25231862|expert_1|glucose intolerance|DDF|target|healthy human subjects|human
25231862|expert_1|NAS|dietary supplement|influence|glucose intolerance|DDF
25231862|expert_1|NAS-induced dysbiosis|DDF|target|healthy human subjects|human
25231862|expert_1|NAS|dietary supplement|influence|dysbiosis|DDF
25231862|expert_1|NAS|dietary supplement|influence|metabolic abnormalities|DDF
25231862|expert_1|Artificial sweeteners|dietary supplement|influence|glucose intolerance|DDF
25231862|expert_1|Non-caloric artificial sweeteners|dietary supplement|influence|glucose intolerance|DDF
25231862|expert_1|Artificial sweeteners|dietary supplement|impact|gut microbiota|microbiome
33677218|expert_6|depression-like behaviors|DDF|target|Rats|animal
33677218|expert_6|depression-like behaviors|DDF|affect|chronic unpredictable mild stress|DDF
33677218|expert_6|gut microbiota|microbiome|is linked to|depression-like behaviors|DDF
33677218|expert_6|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
33677218|expert_6|neuroinflammation|DDF|target|Rats|animal
36938477|expert_4|Probiotics|dietary supplement|influence|functional constipation|DDF
36938477|expert_4|probiotic intake|dietary supplement|influence|constipation|DDF
36938477|expert_4|constipation|DDF|target|PD patients|human
36938477|expert_4|constipation|DDF|target|patients|human
36938477|expert_4|Parkinson's disease|DDF|target|patients|human
36938477|expert_4|Constipation|DDF|target|PD patients|human
36938477|expert_4|PD|DDF|target|patients|human
31940482|expert_4|Bacillus subtilis probiotic strain PXN21|bacteria|influence|synucleinopathy|DDF
31940482|expert_4|gut|anatomical location|located in|worms|animal
31940482|expert_4|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
31940482|expert_4|Multiple B. subtilis strains|bacteria|interact|bacterial metabolites|chemical
31940482|expert_4|synucleinopathy|DDF|target|young and aging animals|animal
33416892|expert_4|gut microbiome|microbiome|is linked to|inflammation|DDF
33416892|expert_4|gut microbiome|microbiome|is linked to|amyotrophic lateral sclerosis|DDF
33416892|expert_4|gut microbiome|microbiome|is linked to|CNS neurodegenerative diseases|DDF
33416892|expert_4|gut microbiome|microbiome|is linked to|multiple sclerosis|DDF
33416892|expert_4|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
33416892|expert_4|gut microbiome|microbiome|is linked to|Alzheimer's disease|DDF
32600151|expert_4|gut microbiome|microbiome|is linked to|multiple sclerosis|DDF
32600151|expert_4|AD|DDF|change abundance|gut microbiome|microbiome
32600151|expert_4|gut microbiome|microbiome|is linked to|neurological diseases|DDF
32600151|expert_4|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
32600151|expert_4|AD|DDF|target|patient|human
32600151|expert_4|AD|DDF|target|patients|human
31302116|expert_1|generalized anxiety|DDF|target|Women|human
31302116|expert_1|gut microbiota|microbiome|is linked to|mood and anxiety disorders|DDF
31302116|expert_1|major depression|DDF|target|men|human
31302116|expert_1|stress-related disorders|DDF|target|Women|human
31302116|expert_1|gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
31302116|expert_1|gut microbiota|microbiome|is linked to|mental illnesses|DDF
31302116|expert_1|major depression|DDF|target|Women|human
31302116|expert_1|stress-related disorders|DDF|target|men|human
31302116|expert_1|generalized anxiety|DDF|target|men|human
34970638|expert_5|Synapsin-1|chemical|located in|DEX and CUMS groups|animal
34970638|expert_5|glial fibrillary acidic protein|chemical|located in|DEX and CUMS groups|animal
34970638|expert_5|gut microbiota|microbiome|located in|individuals|human
34970638|expert_5|excessive immunosuppression with damaged neuronal synapses|DDF|affect|DEX-induced depression|DDF
34970638|expert_5|hippocampus|anatomical location|located in|DEX and CUMS groups|animal
34970638|expert_5|control (CON) group|animal|used by|ELISA|biomedical technique
34970638|expert_5|Clostridium XVIII|bacteria|located in|DEX-treated mice|animal
34970638|expert_5|DEX|drug|administered|DEX group|animal
34970638|expert_5|IL-1β|chemical|located in|DEX-treated mice|animal
34970638|expert_5|neuroinflammation|DDF|strike|brain|anatomical location
34970638|expert_5|depression|DDF|target|individuals|human
34970638|expert_5|occludin|chemical|located in|DEX-treated mice|animal
34970638|expert_5|dexamethasone (DEX) group|animal|used by|Enzyme-linked immunosorbent assay|biomedical technique
34970638|expert_5|CORT|chemical|located in|DEX-treated mice|animal
34970638|expert_5|Adolescent female mice|animal|used by|western blot|biomedical technique
34970638|expert_5|mild stress (CUMS) group|animal|used by|Enzyme-linked immunosorbent assay|biomedical technique
34970638|expert_5|P2Y12 receptor|chemical|located in|hippocampus|anatomical location
34970638|expert_5|CUMS|DDF|affect|depression-like phenotypes|DDF
34970638|expert_5|dexamethasone (DEX) group|animal|used by|sequencing 16S rDNAs|biomedical technique
34970638|expert_5|dexamethasone|drug|change effect|depression-like phenotypes|DDF
34970638|expert_5|gut microbiota|microbiome|is linked to|depression|DDF
34970638|expert_5|dexamethasone (DEX) group|animal|used by|ELISA|biomedical technique
34970638|expert_5|gut microbiota|microbiome|located in|mice|animal
34970638|expert_5|control (CON) group|animal|used by|western blot|biomedical technique
34970638|expert_5|neuroinflammation|DDF|affect|CUMS-induced depression|DDF
34970638|expert_5|Nestin|chemical|located in|DEX and CUMS groups|animal
34970638|expert_5|mild stress (CUMS) group|animal|used by|ELISA|biomedical technique
34970638|expert_5|mild stress (CUMS) group|animal|used by|sequencing 16S rDNAs|biomedical technique
34970638|expert_5|gut microbiota|microbiome|is linked to|depression-like phenotypes|DDF
34970638|expert_5|P2Y12 receptor|chemical|located in|DEX and CUMS groups|animal
34970638|expert_5|Prevotellaceae|bacteria|located in|CUMS group|animal
34970638|expert_5|Bacilli|bacteria|located in|CUMS group|animal
34970638|expert_5|GFAP|chemical|located in|DEX and CUMS groups|animal
34970638|expert_5|IL-1β|chemical|located in|DEX and CUMS groups|animal
34970638|expert_5|mild stress (CUMS) group|animal|used by|western blot|biomedical technique
34970638|expert_5|Adolescent female mice|animal|used by|Enzyme-linked immunosorbent assay|biomedical technique
34970638|expert_5|solvent|chemical|located in|CON mice|animal
34970638|expert_5|Adolescent female mice|animal|used by|sequencing 16S rDNAs|biomedical technique
34970638|expert_5|dexamethasone (DEX) group|animal|used by|western blot|biomedical technique
34970638|expert_5|depression-like phenotypes|DDF|target|mice|animal
34970638|expert_5|control (CON) group|animal|used by|Enzyme-linked immunosorbent assay|biomedical technique
34970638|expert_5|Adolescent female mice|animal|used by|ELISA|biomedical technique
34970638|expert_5|Desulfovibrio|bacteria|located in|CUMS group|animal
34970638|expert_5|pathobionts|microbiome|is linked to|DEX-induced depression|DDF
34970638|expert_5|control (CON) group|animal|used by|sequencing 16S rDNAs|biomedical technique
34970638|expert_5|severe depression-like behaviours|DDF|target|CUMS and DEX groups|animal
34970638|expert_5|dexamethasone|drug|impact|gut microbiota|microbiome
36931666|expert_2|type 2 diabetes mellitus|DDF|target|patients|human
36931666|expert_2|type 2 diabetes mellitus|DDF|affect|chronic hyperglycaemia-related damage|DDF
36931666|expert_2|T2DM|DDF|affect|chronic hyperglycaemia-related damage|DDF
36931666|expert_2|patients|human|used by|randomised, triple-blind, placebo-controlled trial|biomedical technique
36931666|expert_2|T2DM|DDF|target|patients|human
38686220|expert_4|mild to moderate Parkinson's disease|DDF|target|patients|human
38686220|expert_4|gut microbiome|microbiome|is linked to|PD|DDF
38686220|expert_4|early-stage PD|DDF|target|patients|human
38686220|expert_4|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
38686220|expert_4|PD|DDF|target|patients|human
35798742|expert_7|Oral Lactobacillus|bacteria|located in|PD patients|human
35798742|expert_7|Oral and gut dysbiosis|DDF|affect|PD|DDF
35798742|expert_7|oral and gut microbiome|microbiome|is linked to|PD|DDF
35798742|expert_7|oral and gut microbiota|microbiome|is linked to|PD|DDF
35798742|expert_7|oral and gut microbiome|microbiome|located in|PD patients|human
35798742|expert_7|Oral and gut dysbiosis|DDF|affect|Parkinson's disease|DDF
35798742|expert_7|oral microbiome|microbiome|is linked to|Parkinson's disease|DDF
35798742|expert_7|Parkinson's disease|DDF|target|PD patients|human
35798742|expert_7|PD|DDF|target|PD patients|human
35798742|expert_7|oral and gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
35798742|expert_7|PD-specific gut microbiome|microbiome|is linked to|PD|DDF
35798742|expert_7|glutamate|chemical|located in|PD patients|human
35798742|expert_7|oral and gut microbiome|microbiome|used by|shotgun metagenomic sequencing|biomedical technique
35798742|expert_7|oral and gut microbiome|microbiome|compared to|PD-specific gut microbiome|microbiome
35798742|expert_7|PD-specific gut microbiome|microbiome|used by|shotgun metagenomic sequencing|biomedical technique
35798742|expert_7|oral and gut microbiome|microbiome|located in|healthy controls|human
35798742|expert_7|oral microbiome|microbiome|is linked to|PD|DDF
35798742|expert_7|gut|anatomical location|located in|PD patients|human
35798742|expert_7|arginine|chemical|located in|PD patients|human
37655441|expert_4|Prevotella copri|bacteria|influence|rheumatoid arthritis|DDF
37655441|expert_4|Prevotella copri|bacteria|part of|human gastrointestinal microbiome|microbiome
37655441|expert_4|Prevotella copri|bacteria|influence|Parkinson's disease|DDF
36651663|expert_2|depression|DDF|change abundance|Fusicatenibacter saccharivorans|bacteria
36651663|expert_2|Spanish cohort|human|used by|16S ribosomal RNA gene V3-4 amplicon sequencing|biomedical technique
36651663|expert_2|anxiety|DDF|change abundance|Fusicatenibacter saccharivorans|bacteria
36651663|expert_2|depression|DDF|change abundance|Proteobacteria|bacteria
36651663|expert_2|depression|DDF|target|Spanish cohort|human
36651663|expert_2|PTSD|DDF|target|Spanish cohort|human
36651663|expert_2|individuals|human|used by|16S ribosomal RNA gene V3-4 amplicon sequencing|biomedical technique
36651663|expert_2|posttraumatic stress disorder|DDF|change abundance|Turicibacter sanguinis|bacteria
36651663|expert_2|posttraumatic stress disorder|DDF|change abundance|Anaerostipes|bacteria
36651663|expert_2|PTSD|DDF|change abundance|Fusicatenibacter saccharivorans|bacteria
36651663|expert_2|posttraumatic stress disorder|DDF|change abundance|Fusicatenibacter saccharivorans|bacteria
36651663|expert_2|posttraumatic stress disorder|DDF|change abundance|Lentisphaerae|bacteria
36651663|expert_2|anxiety|DDF|target|Spanish cohort|human
36651663|expert_2|posttraumatic stress disorder|DDF|target|Spanish cohort|human
36651663|expert_2|trait anxiety|DDF|target|Individuals|human
36651663|expert_2|depression|DDF|change abundance|Synergistetes phyla|bacteria
36816743|expert_4|gut microbiota|microbiome|is linked to|neurological diseases|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
31330299|expert_5|traumatic brain injury|DDF|strike|brain|anatomical location
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|peripheral inflammation|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|mental illnesses|DDF
31330299|expert_5|gastrointestinal microbiome|microbiome|located in|brain|anatomical location
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|stress|DDF
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|mental illnesses|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|stress|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|disorders of the central nervous system|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|Parkinson's disease|DDF
31330299|expert_5|gut microbiota|microbiome|located in|brain|anatomical location
31330299|expert_5|gut microbiota|microbiome|is linked to|stroke|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|multiple sclerosis|DDF
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|traumatic brain injury|DDF
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|stroke|DDF
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|multiple sclerosis|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|traumatic brain injury|DDF
31330299|expert_5|gut microbiota|microbiome|is linked to|peripheral inflammation|DDF
31330299|expert_5|gastrointestinal microbiota|microbiome|is linked to|Alzheimer's disease|DDF
32188376|expert_6|major depression|DDF|affect|morbidity|DDF
32188376|expert_6|Bipolar disorder|DDF|affect|disability|DDF
32188376|expert_6|major depression|DDF|affect|reduced life expectancy|DDF
32188376|expert_6|Bipolar disorder|DDF|affect|reduced life expectancy|DDF
32188376|expert_6|mood disorders|DDF|target|People|human
32188376|expert_6|Neurocognitive dysfunction|DDF|affect|mood disorders|DDF
32188376|expert_6|Neurocognitive dysfunction|DDF|affect|social dysfunction|DDF
32188376|expert_6|major depression|DDF|affect|disability|DDF
32188376|expert_6|Bipolar disorder|DDF|affect|morbidity|DDF
27319972|expert_7|gut|anatomical location|located in|adult human|human
27319972|expert_7|Early life stress|DDF|strike|intestine|anatomical location
27319972|expert_7|early life stress|DDF|affect|adult psychopathology|DDF
36699448|expert_2|gut microbiome|microbiome|is linked to|depression|DDF
36699448|expert_2|depression|DDF|target|Asian, Chinese people|human
36699448|expert_2|major depressive disorder|DDF|target|Asian, Chinese group|human
36699448|expert_2|major depressive disorder|DDF|change abundance|Pseudomonades|bacteria
36699448|expert_2|gut microbiome|microbiome|located in|Asian, Chinese people|human
36699448|expert_2|MDD|DDF|target|Asian, Chinese group|human
36699448|expert_2|gut microbiome|microbiome|is linked to|major depressive disorder|DDF
36699448|expert_2|gut microbiome|microbiome|is linked to|MDD|DDF
36699448|expert_2|major depressive disorder|DDF|change abundance|Actinobacteria|bacteria
37193253|expert_2|anxiety disorder|DDF|affect|gut dysbiosis|DDF
37193253|expert_2|Main gut microbiota alterations|DDF|change abundance|gut microbiota|microbiome
37193253|expert_2|pSS|DDF|is a|psychological disorders|DDF
37193253|expert_2|Gut Dysbiosis|DDF|target|Primary Sjögren's Syndrome-Mediated Dry Eye Patients|human
37193253|expert_2|gut dysbiosis|DDF|affect|anxiety disorder|DDF
37193253|expert_2|Odoribacter|bacteria|influence|pSS|DDF
37193253|expert_2|gut microbiota|microbiome|is linked to|pSS|DDF
37193253|expert_2|Dry eye discomfort|DDF|affect|anxiety disorders|DDF
37193253|expert_2|pSS-mediated dry eye|DDF|target|patients|human
37193253|expert_2|Anxiety Disorders|DDF|target|Primary Sjögren's Syndrome-Mediated Dry Eye Patients|human
37193253|expert_2|Main gut microbiota alterations|DDF|affect|pSS-mediated dry eye|DDF
37193253|expert_2|anxiety|DDF|affect|pSS|DDF
37193253|expert_2|patients|human|used by|16S ribosomal RNA gene sequencing|biomedical technique
37193253|expert_2|gut microbiota|microbiome|is linked to|ocular conditions|DDF
37193253|expert_2|Bacteroidetes|bacteria|influence|pSS|DDF
37193253|expert_2|ocular conditions|DDF|affect|pSS|DDF
37193253|expert_2|Main gut microbiota alterations|DDF|affect|anxiety|DDF
37193253|expert_2|gut microbiota|microbiome|is linked to|anxiety disorder|DDF
37193253|expert_2|Prevotella|bacteria|influence|Dry eye discomfort|DDF
37193253|expert_2|Primary Sjögren's syndrome|DDF|is a|psychological disorders|DDF
33505487|expert_7|cytokines|chemical|located in|CFC patients|human
33505487|expert_7|Pseudobutyrivibrio|bacteria|located in|experiment group|human
33505487|expert_7|cytokines|chemical|impact|Pseudobutyrivibrio|bacteria
33505487|expert_7|Gut Microbiome|microbiome|located in|Functional Constipation Patients|human
33505487|expert_7|CFC|DDF|target|CFC patients|human
33505487|expert_7|gut microbiome|microbiome|located in|CFC patients|human
33505487|expert_7|gut microbiome|microbiome|located in|experimental and control groups|human
33505487|expert_7|Fusicatenibacter|bacteria|located in|experiment group|human
33505487|expert_7|Ruminiclostridium|bacteria|located in|experiment group|human
34692176|expert_5|ulcerative colitis|DDF|is a|IBDs|DDF
34692176|expert_5|IBD|DDF|target|IBD patients|human
34692176|expert_5|ulcerative colitis|DDF|is a|idiopathic disorders|DDF
34692176|expert_5|UC|DDF|is a|IBDs|DDF
34692176|expert_5|CD|DDF|is a|idiopathic disorders|DDF
34692176|expert_5|Inflammatory bowel diseases|DDF|target|IBD patients|human
34692176|expert_5|UC|DDF|is a|idiopathic disorders|DDF
34692176|expert_5|CD|DDF|is a|IBDs|DDF
34692176|expert_5|pathophysiology of IBD|DDF|target|IBD patients|human
34692176|expert_5|Crohn's disease|DDF|is a|IBDs|DDF
34692176|expert_5|Inflammatory bowel diseases|DDF|is a|complex chronic inflammatory disorders|DDF
34692176|expert_5|IBDs|DDF|is a|complex chronic inflammatory disorders|DDF
34692176|expert_5|Crohn's disease|DDF|is a|idiopathic disorders|DDF
34692176|expert_5|IBDs|DDF|target|IBD patients|human
31539679|expert_1|antibiotic cocktail|drug|impact|Proteobacteria|bacteria
31539679|expert_1|prefrontal cortex|anatomical location|located in|antibiotic-treated mice|animal
31539679|expert_1|antibiotic-induced microbiome depletion|DDF|affect|anhedonia|DDF
31539679|expert_1|host gut|anatomical location|located in|mice|animal
31539679|expert_1|CSDS|DDF|target|mice|animal
31539679|expert_1|chronic social defeat stress|DDF|target|adult mice|animal
31539679|expert_1|gut bacteria|bacteria|influence|CSDS-induced anhedonia|DDF
31539679|expert_1|antibiotic-induced microbiome depletion|DDF|target|adult mice|animal
31539679|expert_1|anhedonia|DDF|target|mice|animal
31539679|expert_1|CSDS|DDF|target|adult mice|animal
31539679|expert_1|gut microbiota|microbiome|located in|antibiotic-treated group|animal
31539679|expert_1|antibiotic cocktail|drug|impact|gut microbiota|microbiome
31539679|expert_1|CSDS|DDF|change abundance|gut microbiota|microbiome
35207632|expert_3|Gastrointestinal Dysfunction|DDF|affect|Parkinson's Disease|DDF
35207632|expert_3|GI dysfunction|DDF|affect|PD|DDF
35207632|expert_3|PD|DDF|target|people|human
37607587|expert_2|gut microbiome|microbiome|is linked to|neurodegenerative diseases|DDF
37607587|expert_2|gut microbiome|microbiome|is linked to|cancer|DDF
37607587|expert_2|Gastrointestinal Dysfunction|DDF|affect|Neurological and Neurodegenerative Disorders|DDF
37607587|expert_2|Dysbiosis|DDF|affect|inflammation|DDF
37607587|expert_2|gut microbiome|microbiome|is linked to|metabolic syndrome|DDF
37607587|expert_2|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
37607587|expert_2|gut microbiome|microbiome|is linked to|Alzheimer's disease|DDF
37607587|expert_2|dysfunctional microbiome|DDF|affect|inflammation|DDF
37607587|expert_2|gut microbiome|microbiome|is linked to|neurodegenerative disorders|DDF
21167931|expert_3|human depression|DDF|affect|chronic inflammatory disorders|DDF
21167931|expert_3|proinflammatory cytokines|chemical|influence|depression|DDF
21167931|expert_3|central nervous system (CNS) antigens|chemical|influence|psychological stress|DDF
21167931|expert_3|IFN-α|chemical|influence|depression|DDF
21167931|expert_3|central nervous system (CNS) antigens|chemical|influence|nerve injury|DDF
21167931|expert_3|human depression|DDF|interact|proinflammatory cytokines|chemical
21167931|expert_3|IL-2|chemical|influence|depression|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|autism spectrum disorder|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|depression|DDF
35317228|expert_5|brain disorder|DDF|strike|brain|anatomical location
35317228|expert_5|gut microbiome|microbiome|is linked to|neurodegenerative diseases|DDF
35317228|expert_5|anxiety|DDF|is a|neuropsychiatric diseases|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|neuropsychiatric and neurodegenerative disorders|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|neuropsychiatric or neurodegenerative disorders|DDF
35317228|expert_5|autism spectrum disorder|DDF|is a|neuropsychiatric diseases|DDF
35317228|expert_5|Parkinson's disease|DDF|is a|neurodegenerative diseases|DDF
35317228|expert_5|Alzheimer's disease|DDF|is a|neurodegenerative diseases|DDF
35317228|expert_5|gut microbiome|microbiome|located in|brain|anatomical location
35317228|expert_5|gut microbiome|microbiome|is linked to|anxiety|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|Alzheimer's disease|DDF
35317228|expert_5|gut microbiome|microbiome|is linked to|neuropsychiatric diseases|DDF
35317228|expert_5|depression|DDF|is a|neuropsychiatric diseases|DDF
33287442|expert_4|probiotic supplementation|dietary supplement|impact|gut microbiota|microbiome
33287442|expert_4|gut microbiota|microbiome|is linked to|breast cancer|DDF
33287442|expert_4|prebiotic|dietary supplement|impact|gut microbiota|microbiome
25173628|expert_3|HFD-shaped microbiota|microbiome|is linked to|neuroinflammation|DDF
25173628|expert_3|HFD microbiota|microbiome|change expression|ionized calcium-binding adapter molecule 1|gene
25173628|expert_3|Obese-type gut microbiota|microbiome|is linked to|neurobehavioral changes|DDF
25173628|expert_3|HFD microbiota|microbiome|change expression|toll-like receptor 4|gene
25173628|expert_3|dementia|DDF|affect|obesity|DDF
25173628|expert_3|depression|DDF|affect|obesity|DDF
25173628|expert_3|HFD microbiota|microbiome|change expression|toll-like receptor 2|gene
25173628|expert_3|gut microbiota|microbiome|is linked to|obesity|DDF
25173628|expert_3|mental illness|DDF|affect|obesity|DDF
25173628|expert_3|gut dysbiosis|DDF|affect|neurologic dysfunction|DDF
25173628|expert_3|control diet microbiota|microbiome|located in|mice|animal
25173628|expert_3|HFD microbiota|microbiome|located in|mice|animal
32431588|expert_6|α-synuclein|chemical|influence|synucleinopathy|DDF
32431588|expert_6|3-HPPA|chemical|influence|intracellular α-syn seeding aggregation|DDF
32431588|expert_6|3,4-diHBA|chemical|influence|intracellular α-syn seeding aggregation|DDF
32431588|expert_6|α-synuclein|chemical|influence|multiple system atrophy|DDF
32431588|expert_6|Parkinson's disease|DDF|affect|synucleinopathy|DDF
32431588|expert_6|α-synuclein|chemical|influence|Parkinson's disease|DDF
32431588|expert_6|PD|DDF|affect|MSA|DDF
32431588|expert_6|probiotic|dietary supplement|influence|α-synucleinopathies|DDF
32431588|expert_6|α-syn|chemical|influence|MSA|DDF
32431588|expert_6|α-syn|chemical|influence|PD|DDF
32431588|expert_6|4-HBA|chemical|influence|intracellular α-syn seeding aggregation|DDF
32431588|expert_6|Parkinson's disease|DDF|affect|MSA|DDF
32431588|expert_6|PD|DDF|affect|multiple system atrophy|DDF
32431588|expert_6|Gut Microbiome-Modified Polyphenolic Compounds|chemical|influence|α-Synucleinopathies|DDF
32431588|expert_6|3-HBA|chemical|influence|intracellular α-syn seeding aggregation|DDF
32431588|expert_6|PD|DDF|affect|synucleinopathy|DDF
32431588|expert_6|α-synuclein|chemical|influence|MSA|DDF
32431588|expert_6|α-synuclein|chemical|influence|PD|DDF
32431588|expert_6|3-HPPA|chemical|influence|MSA-induced aggregation of monomer|DDF
32431588|expert_6|α-syn|chemical|influence|Parkinson's disease|DDF
32431588|expert_6|α-syn|chemical|influence|synucleinopathy|DDF
32431588|expert_6|α-syn pathology|DDF|strike|brain regions|anatomical location
32431588|expert_6|α-syn|chemical|influence|multiple system atrophy|DDF
32431588|expert_6|synbiotic|dietary supplement|influence|α-synucleinopathies|DDF
32431588|expert_6|prebiotic|dietary supplement|influence|α-synucleinopathies|DDF
32431588|expert_6|Parkinson's disease|DDF|affect|multiple system atrophy|DDF
33819374|expert_3|human gut microbiome|microbiome|is linked to|cardiovascular diseases|DDF
33819374|expert_3|human gut microbiome|microbiome|is linked to|diabetes|DDF
33819374|expert_3|Trimethylamine|chemical|influence|dauer formation|DDF
33819374|expert_3|Trimethylamine|chemical|influence|neurodegeneration|DDF
28843021|expert_1|idiopathic rapid eye movement sleep behavior disorder patients|human|used by|16S and 18S ribosomal RNA amplicon sequencing|biomedical technique
28843021|expert_1|PD|DDF|change abundance|gut microbes|bacteria
28843021|expert_1|PD patients|human|used by|16S and 18S ribosomal RNA amplicon sequencing|biomedical technique
28843021|expert_1|PD|DDF|change abundance|Akkermansia|bacteria
28843021|expert_1|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
28843021|expert_1|gut microbiota|microbiome|is linked to|PD|DDF
28843021|expert_1|healthy controls|human|used by|16S and 18S ribosomal RNA amplicon sequencing|biomedical technique
34004259|expert_6|SCFAs|chemical|located in|adult mice|animal
34004259|expert_6|CNO|chemical|impact|gut microbiota|microbiome
34004259|expert_6|gut microbiota|microbiome|located in|adult mice|animal
34004259|expert_6|gut microbiota|microbiome|located in|mice|animal
34004259|expert_6|gut microbiota|microbiome|located in|control mice|animal
34004259|expert_6|gastrointestinal microbiota|microbiome|located in|brain|anatomical location
34004259|expert_6|C21|chemical|impact|gut microbiota|microbiome
34004259|expert_6|DREADD ligands|drug|impact|gut microbiota|microbiome
34004259|expert_6|short-chain fatty acids|chemical|located in|adult mice|animal
33301807|expert_6|SCI|DDF|affect|gut dysbiosis|DDF
33301807|expert_6|gut microbiota|microbiome|is linked to|SCI|DDF
33301807|expert_6|SCI|DDF|affect|anxiety and depression|DDF
33301807|expert_6|SCI|DDF|affect|neuropathic pain|DDF
33301807|expert_6|SCI|DDF|affect|intestinal dysfunction|DDF
33301807|expert_6|SCI|DDF|affect|metabolic disorders|DDF
33301807|expert_6|spinal cord injury|DDF|affect|intestinal dysfunction|DDF
27930574|expert_5|Prebiotics|dietary supplement|impact|gut microbiota|microbiome
32667590|expert_5|gut microbiota|microbiome|is linked to|schizophrenia|DDF
32667590|expert_5|gut microbiota|microbiome|is linked to|dementia|DDF
32667590|expert_5|intestinal metabolites of microbial origin|chemical|located in|small and large intestine|anatomical location
32667590|expert_5|intestinal microbiota|microbiome|located in|small and large intestine|anatomical location
32667590|expert_5|gut microbiota|microbiome|is linked to|Alzheimer disease|DDF
32667590|expert_5|intestinal microbiota|microbiome|is linked to|neurological and psychiatric disorders|DDF
32667590|expert_5|intestinal metabolites of microbial origin|chemical|produced by|intestinal microbiota|microbiome
32667590|expert_5|prebiotics|dietary supplement|influence|neuropsychiatric disorders|DDF
32667590|expert_5|probiotics|dietary supplement|influence|neuropsychiatric disorders|DDF
32667590|expert_5|gut microbiota|microbiome|is linked to|autism spectrum disorder|DDF
32667590|expert_5|gut microbiota|microbiome|is linked to|major depressive disorder|DDF
32667590|expert_5|gut microbiota|microbiome|is linked to|anxiety|DDF
32667590|expert_5|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
32667590|expert_5|gut microbiota|microbiome|is linked to|bipolar disorder|DDF
32667590|expert_5|gut microbiota|microbiome|located in|brain|anatomical location
30033172|expert_2|gut microbiota|microbiome|is linked to|non-communicable diseases|DDF
30033172|expert_2|gut microbiota|microbiome|located in|human host|human
30033172|expert_2|gut microbiota|microbiome|is linked to|intestinal dysbiosis|DDF
30033172|expert_2|gut microbiota|microbiome|is linked to|dietary-induced alterations|DDF
27763700|expert_6|lactoferrin|chemical|influence|stress|DDF
27763700|expert_6|GOS|dietary supplement|impact|gut bacteria|bacteria
27763700|expert_6|PDX|dietary supplement|impact|gut bacteria|bacteria
27763700|expert_6|galactooligosaccharide|dietary supplement|influence|stress|DDF
27763700|expert_6|GOS|dietary supplement|influence|stress|DDF
27763700|expert_6|PDX|dietary supplement|influence|stress|DDF
27763700|expert_6|GOS|dietary supplement|influence|stress-induced learned helplessness|DDF
27763700|expert_6|inescapable stress|DDF|target|rats|animal
27763700|expert_6|bioactive milk fractions|dietary supplement|influence|stress|DDF
27763700|expert_6|prebiotics|dietary supplement|influence|stress resistance|DDF
27763700|expert_6|PDX|dietary supplement|influence|stress-induced learned helplessness|DDF
27763700|expert_6|LAC|chemical|influence|stress-evoked decreases in mRNA|DDF
27763700|expert_6|prebiotics|dietary supplement|influence|stress|DDF
27763700|expert_6|LAC|chemical|impact|gut bacteria|bacteria
27763700|expert_6|polydextrose|dietary supplement|influence|stress|DDF
27763700|expert_6|LAC|chemical|influence|stress|DDF
27763700|expert_6|GOS|dietary supplement|impact|Lactobacillus spp.|bacteria
27763700|expert_6|PDX|dietary supplement|impact|Lactobacillus spp.|bacteria
27763700|expert_6|LAC|chemical|influence|stress-induced learned helplessness|DDF
27763700|expert_6|GOS|dietary supplement|influence|stress-evoked decreases in mRNA|DDF
27763700|expert_6|PDX|dietary supplement|influence|stress-evoked decreases in mRNA|DDF
31383280|expert_7|PMAD|DDF|target|child|human
31383280|expert_7|Maternal Gut Microbiome|microbiome|located in|mother|human
31383280|expert_7|Perinatal mood and anxiety disorders|DDF|target|mother|human
31383280|expert_7|Maternal Gut Microbiome|microbiome|is linked to|PMAD|DDF
31383280|expert_7|Perinatal mood and anxiety disorders|DDF|target|child|human
31383280|expert_7|PMAD|DDF|target|mother|human
38606411|expert_2|gut microbiota|microbiome|is linked to|insomnia disorder|DDF
38606411|expert_2|chronic insomnia disorder|DDF|affect|anxiety|DDF
38606411|expert_2|chronic insomnia disorder|DDF|target|Individuals|human
38606411|expert_2|gut microbiota|microbiome|located in|individuals|human
38606411|expert_2|Insomnia disorder|DDF|is a|clinical sleep and psychiatric disorders|DDF
38606411|expert_2|chronic insomnia disorder|DDF|affect|impaired intestinal barrier function|DDF
38606411|expert_2|insomnia disorder|DDF|target|individuals|human
38606411|expert_2|chronic insomnia disorder|DDF|target|patients|human
38606411|expert_2|healthy volunteers|human|used by|ELISA technology|biomedical technique
38606411|expert_2|intestinal barrier|anatomical location|located in|individuals|human
38606411|expert_2|patients|human|used by|ELISA technology|biomedical technique
28073356|expert_7|gastrointestinal helminth infections|DDF|affect|childhood cognitive morbidity|DDF
28073356|expert_7|Gut microbiota disturbance|DDF|affect|helminth infection|DDF
28073356|expert_7|helminth infection|DDF|target|children|human
28073356|expert_7|helminth infections|DDF|affect|cognitive impairment|DDF
28073356|expert_7|Gut microbiota disturbance|DDF|target|children|human
28073356|expert_7|helminth infections|DDF|target|school-aged children|human
28073356|expert_7|cognitive impairment|DDF|target|school-aged children|human
28073356|expert_7|gut microbiota|microbiome|located in|brain|anatomical location
37764277|expert_3|Baicalin|chemical|influence|intestinal disorders|DDF
37764277|expert_3|Baicalin|chemical|impact|intestinal microorganisms|bacteria
37764277|expert_3|baicalin|chemical|influence|gut-brain axis disorders|DDF
37764277|expert_3|Baicalin|chemical|influence|obesity|DDF
34357134|expert_2|social cognitive impairment|DDF|affect|schizophrenia|DDF
34357134|expert_2|schizophrenia|DDF|target|patients|human
37049591|expert_3|gut microbiota|microbiome|located in|major depressive disorder (MDD) patients|human
37049591|expert_3|intestinal flora|microbiome|located in|MDD patients|human
37049591|expert_3|Kyn|chemical|located in|Venous blood|anatomical location
37049591|expert_3|tryptophan|chemical|located in|Venous blood|anatomical location
37049591|expert_3|kynurenine|chemical|located in|Venous blood|anatomical location
37049591|expert_3|gut microbiota|microbiome|is linked to|neurological and psychiatric diseases|DDF
37049591|expert_3|Ido|chemical|located in|Venous blood|anatomical location
37049591|expert_3|Trp|chemical|located in|Venous blood|anatomical location
37049591|expert_3|plasma indoleamine-2,3-dioxygenase|chemical|located in|Venous blood|anatomical location
37049591|expert_3|Major Depressive Disorder|DDF|target|Patients|human
37049591|expert_3|MDD|DDF|target|patients|human
37156128|expert_2|DN SCZ|human|used by|16s rRNA sequencing|biomedical technique
37156128|expert_2|schizophrenia|DDF|change abundance|Ruminococcus|bacteria
37156128|expert_2|gut microbiota|microbiome|located in|drug-naïve (DN SCZ) and risperidone-treated SCZ patients|human
37156128|expert_2|schizophrenia|DDF|target|patients|human
37156128|expert_2|schizophrenia|DDF|change abundance|Bifidobacterium|bacteria
37156128|expert_2|schizophrenia|DDF|change abundance|Clostridium_sensu_stricto_1|bacteria
37156128|expert_2|gut microbiota|microbiome|located in|HCs|human
37156128|expert_2|gut microbiota|microbiome|located in|healthy controls|human
37156128|expert_2|gut microbiota|microbiome|located in|RISP SCZ|human
37156128|expert_2|gut microbiome|microbiome|is linked to|schizophrenia|DDF
37156128|expert_2|RISP SCZ|human|used by|16s rRNA sequencing|biomedical technique
37156128|expert_2|HCs|human|used by|16s rRNA sequencing|biomedical technique
37156128|expert_2|human gut microbiome|microbiome|is linked to|neuropsychiatric disorders|DDF
37156128|expert_2|schizophrenia|DDF|change abundance|UCG005|bacteria
31769847|expert_7|probiotics|dietary supplement|impact|gut microbiota|microbiome
31769847|expert_7|Probiotics|dietary supplement|administered|psychiatric patients|human
31769847|expert_7|prebiotics|dietary supplement|administered|psychiatric patients|human
31769847|expert_7|microbial dysbiosis|DDF|affect|psychiatric diseases|DDF
31769847|expert_7|probiotics|dietary supplement|influence|psychiatric disorders|DDF
31769847|expert_7|schizophrenia|DDF|target|patients|human
31769847|expert_7|Probiotics|dietary supplement|influence|psychiatric disorders|DDF
31769847|expert_7|probiotics|dietary supplement|influence|autism spectrum disorders|DDF
31769847|expert_7|gut microbiota|microbiome|is linked to|psychiatric diseases|DDF
31769847|expert_7|prebiotics|dietary supplement|impact|gut microbiota|microbiome
31769847|expert_7|probiotics|dietary supplement|administered|patients|human
31769847|expert_7|psychiatric disorders|DDF|target|psychiatric patients|human
31769847|expert_7|psychiatric disorder|DDF|target|patients|human
31769847|expert_7|prebiotics|dietary supplement|administered|patients|human
31769847|expert_7|Probiotics|dietary supplement|influence|major depressive disorder|DDF
31769847|expert_7|psychiatric diseases|DDF|target|psychiatric patients|human
31769847|expert_7|prebiotics|dietary supplement|influence|psychiatric disorders|DDF
31769847|expert_7|Probiotics|dietary supplement|influence|Alzheimer's disease|DDF
31769847|expert_7|acute mania|DDF|target|patients|human
31769847|expert_7|probiotics|dietary supplement|administered|psychiatric patients|human
36072564|expert_6|gut microbiome|microbiome|is linked to|brain disorders|DDF
36072564|expert_6|gut microbiome|microbiome|is linked to|depression|DDF
36072564|expert_6|microbiota-derived metabolites|chemical|located in|older individuals|human
36072564|expert_6|gut microbiome|microbiome|is linked to|age-related diseases|DDF
36072564|expert_6|gut microbiome|microbiome|is linked to|anxiety|DDF
36072564|expert_6|gut microbiome|microbiome|is linked to|Alzheimer's and Parkinson's disease|DDF
36072564|expert_6|gut microbiome|microbiome|is linked to|schizophrenia|DDF
36072564|expert_6|cognitive defects|DDF|target|older individuals|human
36072564|expert_6|choline|chemical|influence|age-related diseases|DDF
36072564|expert_6|microbiota-derived metabolites|chemical|influence|age-associated diseases|DDF
36072564|expert_6|trimethylamine|chemical|influence|age-related diseases|DDF
36072564|expert_6|age-associated diseases|DDF|target|older individuals|human
31596658|expert_6|gut microbiome|microbiome|located in|gut|anatomical location
31596658|expert_6|gut microbiome|microbiome|located in|mouth|anatomical location
30518033|expert_6|gut microbiota|microbiome|is linked to|anxiety|DDF
30518033|expert_6|gut microbiota|microbiome|is linked to|psychological symptoms|DDF
30518033|expert_6|gut microbiota|microbiome|is linked to|host anxiety levels|DDF
30518033|expert_6|Gut Microbiota Composition|microbiome|is linked to|Anxiety Levels|DDF
34216356|expert_6|gut microbiome|microbiome|is linked to|neurodegenerative diseases|DDF
34216356|expert_6|Gut Microbiome|microbiome|is linked to|Neurodegenerative Diseases|DDF
34216356|expert_6|intestinal microbiota|microbiome|is linked to|Parkinson's disease|DDF
34216356|expert_6|gut microbiome|microbiome|used by|assay techniques|biomedical technique
34216356|expert_6|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
34216356|expert_6|intestinal microbiota|microbiome|is linked to|Alzheimer's disease|DDF
26627987|expert_2|gut disorders|DDF|affect|Alzheimer's and Parkinson's diseases|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|IBS|DDF
26627987|expert_2|gut disorders|DDF|affect|irritable bowel syndrome|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|Alzheimer's and Parkinson's diseases|DDF
26627987|expert_2|gut disorders|DDF|affect|ulcerative colitis|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|gut disorders|DDF
26627987|expert_2|gut disorders|DDF|affect|central nervous system (CNS) disorders|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|irritable bowel syndrome|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|central nervous system (CNS) disorders|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|UC|DDF
26627987|expert_2|gut microbiome|microbiome|is linked to|ulcerative colitis|DDF
35203906|expert_3|SARS-CoV-2|DDF|affect|Parkinson's disease|DDF
35203906|expert_3|PD/parkinsonism|DDF|affect|viral infection|DDF
35203906|expert_3|viral infection|DDF|target|PD patients|human
35203906|expert_3|impairment of cough reflex|DDF|target|elderly population|human
35203906|expert_3|SARS-CoV-2|DDF|affect|PD|DDF
35203906|expert_3|coronavirus disease 2019|DDF|affect|PD|DDF
35203906|expert_3|COVID-19|DDF|affect|PD|DDF
35203906|expert_3|COVID-19|DDF|target|PD patients|human
35203906|expert_3|rigidity of respiratory muscles|DDF|target|elderly population|human
35203906|expert_3|dyspnea|DDF|target|elderly population|human
31488882|expert_4|sodium oligomannate|drug|change effect|neuroinflammation|DDF
31488882|expert_4|Sodium oligomannate|dietary supplement|influence|gut bacterial amino acids-shaped neuroinflammation|DDF
31488882|expert_4|sodium oligomannate|drug|interact|phenylalanine|chemical
31488882|expert_4|AD progression|DDF|interact|isoleucine|chemical
31488882|expert_4|GV-971|drug|change effect|gut dysbiosis|DDF
31488882|expert_4|sodium oligomannate|drug|change effect|cognition impairment|DDF
31488882|expert_4|GV-971|drug|change effect|neuroinflammation|DDF
31488882|expert_4|GV-971|drug|interact|isoleucine|chemical
31488882|expert_4|MCI|DDF|target|patients|human
31488882|expert_4|AD|DDF|affect|mild cognitive impairment|DDF
31488882|expert_4|mild cognitive impairment|DDF|target|patients|human
31488882|expert_4|AD progression|DDF|interact|phenylalanine|chemical
31488882|expert_4|AD|DDF|affect|MCI|DDF
31488882|expert_4|sodium oligomannate|drug|interact|isoleucine|chemical
31488882|expert_4|GV-971|drug|change effect|cognition impairment|DDF
31488882|expert_4|Sodium oligomannate|dietary supplement|influence|Alzheimer's disease progression|DDF
31488882|expert_4|GV-971|drug|interact|phenylalanine|chemical
31488882|expert_4|Sodium oligomannate|dietary supplement|impact|gut microbiota|microbiome
31488882|expert_4|sodium oligomannate|drug|change effect|gut dysbiosis|DDF
37502424|expert_3|mildly impaired cognition|DDF|target|community-dwelling older adults|human
37502424|expert_3|mildly impaired cognitive functions|DDF|target|community-dwelling individuals|human
38011787|expert_4|CPT|chemical|influence|depression|DDF
38011787|expert_4|Cryptotanshinone|chemical|impact|gut microbiota|microbiome
38011787|expert_4|Cryptotanshinone|chemical|influence|CUMS induced depressive symptoms|DDF
38011787|expert_4|gut microbiota|microbiome|used by|16 S rDNA analysis|biomedical technique
38011787|expert_4|gut microbiota|microbiome|located in|rats|animal
37400971|expert_3|MMD|DDF|affect|behavioral impairments|DDF
37400971|expert_3|MMD|DDF|affect|obsessive-compulsive-like behavior|DDF
37400971|expert_3|psychiatric-related abnormalities|DDF|change abundance|maternal gut microbiota|microbiome
37400971|expert_3|experimental perinatal MMD|DDF|target|offspring|animal
31132457|expert_3|GMC|microbiome|located in|toddler|human
31132457|expert_3|GMC|microbiome|located in|young infants|human
34408160|expert_5|alpha-synuclein|chemical|influence|PD|DDF
34408160|expert_5|alpha-synuclein|chemical|influence|Parkinson's disease|DDF
34408160|expert_5|pathogenesis of PD|DDF|affect|PD|DDF
34408160|expert_5|opportunistic pathogens|bacteria|influence|dysbiosis of gut microbiome|DDF
34408160|expert_5|pathogenesis of PD|DDF|affect|Parkinson's disease|DDF
34408160|expert_5|alpha-synuclein|chemical|influence|familial PD|DDF
34408160|expert_5|opportunistic pathogens|bacteria|influence|PD|DDF
34408160|expert_5|dysbiosis of gut microbiome|DDF|affect|Parkinson's disease|DDF
34408160|expert_5|gut microbiome|microbiome|located in|gut|anatomical location
34408160|expert_5|gut microbiome|microbiome|is linked to|pathogenesis of PD|DDF
34408160|expert_5|dysbiosis of gut microbiome|DDF|affect|PD|DDF
31377712|expert_1|Multiple sclerosis|DDF|affect|disability|DDF
31377712|expert_1|MS|DDF|target|young <u>a</u>dults|human
31377712|expert_1|MS|DDF|affect|disability|DDF
31377712|expert_1|MS|DDF|target|young patients|human
31377712|expert_1|Multiple sclerosis|DDF|target|young adults|human
31377712|expert_1|gut microbiota|microbiome|located in|young adults|human
31377712|expert_1|MS|DDF|target|young adults|human
31377712|expert_1|young adults|human|used by|cerebrospinal fluid and blood biomarkers|biomedical technique
31377712|expert_1|young adults|human|used by|neurological examinations|biomedical technique
31377712|expert_1|young adults|human|used by|MRI|biomedical technique
31377712|expert_1|MS|DDF|target|patients|human
38331354|expert_4|liver cirrhosis|DDF|target|mice|animal
38331354|expert_4|liver cirrhosis|DDF|target|patients|human
38331354|expert_4|Dysbiosis|DDF|affect|depression|DDF
33692356|expert_5|dysbiosis|DDF|affect|pro-inflammatory status|DDF
33692356|expert_5|PD-specific microbiota|microbiome|located in|PD patients|human
33692356|expert_5|recurrent gastrointestinal symptoms|DDF|target|PD patients|human
33692356|expert_5|gut microbes|microbiome|is linked to|PD|DDF
33692356|expert_5|alterations of the enteric nervous system|DDF|affect|Parkinson's disease (PD) symptomatology and pathophysiology|DDF
33692356|expert_5|pro-inflammatory status|DDF|affect|recurrent gastrointestinal symptoms|DDF
33692356|expert_5|gastrointestinal symptoms|DDF|affect|Parkinson's disease (PD) symptomatology and pathophysiology|DDF
33692356|expert_5|gut microbiota|microbiome|is linked to|Parkinson's disease (PD) symptomatology and pathophysiology|DDF
33692356|expert_5|gut microbiota|microbiome|located in|PD and controls|human
33692356|expert_5|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
33692356|expert_5|gut microbiota|microbiome|located in|PD patients|human
33692356|expert_5|Lachnospiraceae|bacteria|interact|short-chain fatty acids|chemical
33692356|expert_5|alterations of the enteric nervous system|DDF|affect|PD|DDF
33692356|expert_5|gastrointestinal symptoms|DDF|affect|PD|DDF
33692356|expert_5|PD-associated microbiome|microbiome|located in|PD patients|human
33692356|expert_5|Faecalibacterium|bacteria|interact|short-chain fatty acids|chemical
33692356|expert_5|gut microbes|microbiome|is linked to|Parkinson's disease (PD) symptomatology and pathophysiology|DDF
33692356|expert_5|gut microbes|microbiome|is linked to|neurodegenerative diseases|DDF
33692356|expert_5|gut microbiota|microbiome|is linked to|PD|DDF
27566465|expert_3|probiotics|dietary supplement|impact|gut microbiota|microbiome
27566465|expert_3|AD|DDF|change abundance|gut microbiota|microbiome
27566465|expert_3|Alzheimer's disease|DDF|affect|impaired cognition|DDF
27566465|expert_3|Pathogenic microbes infection|DDF|affect|AD|DDF
27566465|expert_3|antibiotics|drug|impact|gut microbiota|microbiome
27566465|expert_3|AD|DDF|affect|impaired cognition|DDF
27566465|expert_3|gut microbiota|microbiome|is linked to|AD|DDF
27566465|expert_3|neurodegenerative disorder|DDF|affect|impaired cognition|DDF
29249803|expert_7|Deltaproteobacteria|bacteria|located in|susceptible mice|animal
29249803|expert_7|(R)-ketamine|drug|administered|CSDS-susceptible mice|animal
29249803|expert_7|(S)-ketamine|drug|administered|susceptible mice|animal
29249803|expert_7|(R)-ketamine|drug|impact|Deltaproteobacteria|bacteria
29249803|expert_7|Mollicutes|bacteria|located in|susceptible mice|animal
29249803|expert_7|Actinobacteria|bacteria|located in|CSDS-susceptible mice|animal
29249803|expert_7|(R)-ketamine|drug|impact|Mollicutes|bacteria
29249803|expert_7|ketamine enantiomers|drug|administered|CSDS-susceptible mice|animal
29249803|expert_7|ketamine enantiomers|drug|impact|Deltaproteobacteria|bacteria
29249803|expert_7|Butyricimonas|bacteria|located in|susceptible mice|animal
29249803|expert_7|(S)-ketamine|drug|administered|CSDS-susceptible mice|animal
29249803|expert_7|gut microbiota|microbiome|located in|CSDS-susceptible mice|animal
29249803|expert_7|(R)-ketamine|drug|administered|susceptible mice|animal
29249803|expert_7|(R)-ketamine|drug|impact|Butyricimonas|bacteria
29249803|expert_7|Tenericutes|bacteria|located in|CSDS-susceptible mice|animal
29249803|expert_7|(S)-ketamine|drug|impact|Deltaproteobacteria|bacteria
29249803|expert_7|ketamine enantiomers|drug|administered|susceptible mice|animal
29249803|expert_7|ketamine enantiomers|drug|impact|Butyricimonas|bacteria
29249803|expert_7|ketamine enantiomers|drug|change effect|depression|DDF
29249803|expert_7|gut microbiota|microbiome|located in|susceptible mice|animal
29249803|expert_7|(S)-ketamine|drug|impact|Butyricimonas|bacteria
32379622|expert_2|gut microbiome|microbiome|located in|mice|animal
32379622|expert_2|chronic social defeat stress|DDF|target|mice|animal
32379622|expert_2|betaine|dietary supplement|influence|stress-related psychiatric disorders|DDF
32379622|expert_2|Betaine supplementation|dietary supplement|influence|CSDS|DDF
32379622|expert_2|Betaine supplementation|dietary supplement|influence|chronic social defeat stress|DDF
32379622|expert_2|betaine|dietary supplement|impact|gut microbiome|microbiome
32379622|expert_2|gut microbiome|microbiome|used by|Sucrose preference test|biomedical technique
32379622|expert_2|Betaine supplementation|dietary supplement|impact|gut microbiome|microbiome
32379622|expert_2|CSDS|DDF|target|mice|animal
32379622|expert_2|CSDS|DDF|interact|succinic acid|chemical
32379622|expert_2|gut microbiome|microbiome|used by|16S rRNA analysis|biomedical technique
32379622|expert_2|CSDS|DDF|interact|acetic acid|chemical
32379622|expert_2|CSDS|DDF|target|betaine-treated mice|animal
32379622|expert_2|anhedonia|DDF|target|mice|animal
32379622|expert_2|CSDS|DDF|interact|short-chain fatty acids|chemical
32379622|expert_2|CSDS|DDF|target|water-treated mice|animal
32379622|expert_2|betaine supplementation|dietary supplement|influence|anhedonia|DDF
37023596|expert_2|MDD|DDF|target|Patients|human
37023596|expert_2|MDD|DDF|target|patients|human
37023596|expert_2|major depression disorder|DDF|target|patients|human
37023596|expert_2|gut microbiota|microbiome|located in|patients|human
28816544|expert_7|polyunsaturated fatty acids|chemical|influence|inflammation|DDF
28816544|expert_7|PUFAs|chemical|influence|depression|DDF
28816544|expert_7|PUFAs|chemical|influence|inflammation|DDF
28816544|expert_7|gut microbiota|microbiome|is linked to|inflammation|DDF
28816544|expert_7|gut microbiota|microbiome|is linked to|depression|DDF
28816544|expert_7|polyunsaturated fatty acids|chemical|influence|depression|DDF
28816544|expert_7|glucocorticoids|chemical|influence|depression|DDF
28816544|expert_7|glucocorticoids|chemical|influence|inflammation|DDF
31218116|expert_3|gastrointestinal upset|DDF|target|people|human
31218116|expert_3|celiac disease|DDF|target|people|human
31218116|expert_3|Celiac Disease|DDF|target|Inactive Adults|human
31218116|expert_3|celiac disease|DDF|target|inactive adults|human
31218116|expert_3|celiac disease|DDF|target|Individuals|human
34250955|expert_6|PD|DDF|affect|bradykinesia|DDF
34250955|expert_6|upper and lower gastrointestinal issues|DDF|target|patients|human
34250955|expert_6|PD|DDF|affect|postural instability|DDF
34250955|expert_6|gastrointestinal conditions and symptoms|DDF|target|patients|human
34250955|expert_6|gut microbiome|microbiome|is linked to|PD|DDF
34250955|expert_6|initial pathophysiological changes|DDF|strike|gastrointestinal tract|anatomical location
34250955|expert_6|Parkinson's disease|DDF|affect|bradykinesia|DDF
34250955|expert_6|Parkinson's disease|DDF|affect|postural instability|DDF
34250955|expert_6|PD|DDF|strike|gut|anatomical location
34250955|expert_6|PD|DDF|strike|gastrointestinal tract|anatomical location
34250955|expert_6|Parkinson's disease|DDF|affect|rigidity|DDF
34250955|expert_6|prodromal PD subtypes|DDF|strike|gut|anatomical location
34250955|expert_6|PD|DDF|affect|tremor|DDF
34250955|expert_6|Parkinson's disease|DDF|affect|tremor|DDF
34250955|expert_6|PD|DDF|affect|rigidity|DDF
33092203|expert_5|human microbiome|microbiome|used by|16S rRNA technology|biomedical technique
32163822|expert_4|probiotics|dietary supplement|impact|gut microbiota|microbiome
32163822|expert_4|probiotics|dietary supplement|influence|pregnancy related stress|DDF
32163822|expert_4|gut microbiota|microbiome|located in|newborn child|human
32538869|expert_7|CsgA protein|chemical|located in|gut|anatomical location
32538869|expert_7|CsgA|chemical|located in|gut|anatomical location
32538869|expert_7|amyloidogenic protein|chemical|located in|mice|animal
32538869|expert_7|alpha-synuclein|chemical|part of|amyloidogenic human and non-human proteins|chemical
32538869|expert_7|CsgA|chemical|influence|Parkinson's disease|DDF
32538869|expert_7|Parkinson's disease|DDF|target|mice|animal
32538869|expert_7|amyloidogenic protein|chemical|influence|Parkinson's disease|DDF
32538869|expert_7|Alpha-Synuclein|chemical|part of|Human and Non-Human Amyloidogenic Proteins|chemical
32538869|expert_7|CsgA protein|chemical|influence|Parkinson's disease|DDF
32538869|expert_7|amyloidogenic proteins|chemical|impact|gut bacteria|bacteria
32538869|expert_7|amyloidogenic protein|chemical|located in|gut|anatomical location
32538869|expert_7|stable allergenic proteins|chemical|influence|amyloid-related diseases|DDF
32538869|expert_7|CsgA|chemical|influence|amyloid-related diseases|DDF
32538869|expert_7|CsgA|chemical|located in|mice|animal
32538869|expert_7|amyloidogenic protein|chemical|influence|amyloid-related diseases|DDF
32538869|expert_7|CsgA protein|chemical|influence|amyloid-related diseases|DDF
32538869|expert_7|CsgA protein|chemical|located in|mice|animal
32538869|expert_7|amyloidogenic proteins|chemical|influence|amyloid-related diseases|DDF
32538869|expert_7|amyloidogenic proteins|chemical|influence|human diseases|DDF
34884399|expert_4|PD|DDF|change abundance|Bacteroides</i> phylum|bacteria
34884399|expert_4|PD|DDF|change abundance|Proteobacteria|bacteria
34884399|expert_4|PD|DDF|change abundance|Flavonifractor|bacteria
34884399|expert_4|Parkinson's Disease|DDF|target|Patients|human
34884399|expert_4|PD|DDF|change abundance|Corynebacteria|bacteria
34884399|expert_4|PD|DDF|change abundance|Butyricimonas|bacteria
34884399|expert_4|PD|DDF|change abundance|Robinsoniella|bacteria
34884399|expert_4|PD|DDF|change abundance|Actinobacteria|bacteria
34884399|expert_4|PD|DDF|change abundance|Deltaproteobacteria|bacteria
34884399|expert_4|PD|DDF|change abundance|gut microbiota|microbiome
34884399|expert_4|PD|DDF|target|patients|human
33406628|expert_5|Microbially derived toxic bile acids|chemical|influence|Parkinson's disease|DDF
33406628|expert_5|functional microbiota|microbiome|located in|controls|human
33406628|expert_5|Gut Microbiota Dysbiosis|DDF|affect|Parkinson's Disease|DDF
33406628|expert_5|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
33406628|expert_5|appendix microbiome|microbiome|located in|vermiform appendix|anatomical location
33406628|expert_5|lithocholic acid|chemical|located in|PD appendix|anatomical location
33406628|expert_5|deoxycholic acid|chemical|located in|PD appendix|anatomical location
33406628|expert_5|functional microbiota|microbiome|used by|metatranscriptomic analysis|biomedical technique
33406628|expert_5|Gut Microbiota Dysbiosis|DDF|interact|Bile Acids|chemical
33406628|expert_5|PD patients|human|used by|Bile acid analysis|biomedical technique
33406628|expert_5|bacteria responsible for secondary bile acid synthesis|bacteria|influence|microbial dysbiosis|DDF
33406628|expert_5|hydrophobic and secondary bile acids|chemical|located in|PD appendix|anatomical location
33406628|expert_5|appendix|anatomical location|located in|PD patients|human
33406628|expert_5|controls|human|used by|Bile acid analysis|biomedical technique
33406628|expert_5|biliary abnormalities|DDF|affect|PD pathogenesis|DDF
33406628|expert_5|gut microbiome|microbiome|is linked to|Gut Microbiota Dysbiosis|DDF
33406628|expert_5|PD patients|human|used by|metatranscriptomic analysis|biomedical technique
33406628|expert_5|controls|human|used by|metatranscriptomic analysis|biomedical technique
33406628|expert_5|Parkinson's disease|DDF|target|PD patients|human
33406628|expert_5|alterations in mediators of cholesterol homeostasis and lipid metabolism|DDF|strike|PD gut|anatomical location
33406628|expert_5|PD|DDF|target|PD patients|human
33406628|expert_5|PD appendix|anatomical location|located in|PD patients|human
33406628|expert_5|PD gut|anatomical location|located in|PD patients|human
33406628|expert_5|functional microbiota|microbiome|located in|appendix|anatomical location
33406628|expert_5|Microbially derived toxic bile acids|chemical|influence|PD|DDF
33406628|expert_5|disruption in bile acid control|DDF|strike|PD gut|anatomical location
33406628|expert_5|gut microbiome|microbiome|is linked to|PD|DDF
33406628|expert_5|appendix|anatomical location|located in|controls|human
33406628|expert_5|LCA|chemical|located in|PD appendix|anatomical location
33406628|expert_5|DCA|chemical|located in|PD appendix|anatomical location
31260640|expert_3|intestinal microbiota|microbiome|located in|brain|anatomical location
31260640|expert_3|gut microbiota|microbiome|is linked to|psychiatry and other central nervous system (CNS) disorders|DDF
28399458|expert_7|gastrointestinal complaints|DDF|target|offspring|human
28399458|expert_7|depressive disorders|DDF|affect|infants' inflammatory diseases|DDF
28399458|expert_7|psychopathological symptoms|DDF|affect|inflammatory diseases|DDF
28399458|expert_7|maternal anxiety|DDF|affect|infant gastrointestinal complaints|DDF
28399458|expert_7|perinatal distress|DDF|affect|infants' inflammatory diseases|DDF
28399458|expert_7|DSM-IV lifetime anxiety and depressive disorders|DDF|target|(expectant) mothers|human
28399458|expert_7|maternal perinatal distress|DDF|affect|infant inflammatory diseases|DDF
28399458|expert_7|maternal anxiety|DDF|affect|early infant diseases|DDF
28399458|expert_7|anxiety|DDF|affect|diarrhea|DDF
28399458|expert_7|anxiety|DDF|affect|colic complaints|DDF
28399458|expert_7|inflammatory diseases|DDF|target|offspring|human
28399458|expert_7|anxiety|DDF|target|(expectant) mothers|human
28399458|expert_7|anxiety|DDF|affect|gastrointestinal complaints|DDF
28399458|expert_7|depressive disorders|DDF|affect|infant gastrointestinal complaints|DDF
28399458|expert_7|anxiety|DDF|affect|infants' inflammatory diseases|DDF
28399458|expert_7|(expectant) mothers|human|used by|Brief Symptom Inventory|biomedical technique
28399458|expert_7|depressive disorders|DDF|affect|diarrhea|DDF
28399458|expert_7|depressive disorders|DDF|affect|gastrointestinal complaints|DDF
28399458|expert_7|infant inflammatory diseases|DDF|target|offspring|human
28399458|expert_7|depressive disorders|DDF|affect|early infant diseases|DDF
28399458|expert_7|depressive disorders|DDF|affect|colic complaints|DDF
28399458|expert_7|perinatal psychopathological symptoms|DDF|affect|early infant diseases|DDF
28399458|expert_7|depressive disorders|DDF|target|(expectant) mothers|human
28399458|expert_7|infants' inflammatory diseases|DDF|target|offspring|human
28399458|expert_7|(expectant) mothers|human|used by|Composite International Diagnostic Interview for Women|biomedical technique
28399458|expert_7|psychopathological symptoms|DDF|target|(expectant) mothers|human
28399458|expert_7|infant gastrointestinal complaints|DDF|target|offspring|human
28399458|expert_7|Infant inflammatory diseases|DDF|target|offspring|human
28399458|expert_7|gut microbiota|microbiome|is linked to|infant gastrointestinal complaints|DDF
28399458|expert_7|perinatal distress|DDF|affect|gastrointestinal complaints|DDF
30826885|expert_2|gut microbiota|microbiome|is linked to|perinatal mood and anxiety disorders|DDF
30826885|expert_2|cortisol|chemical|influence|PMAD|DDF
30826885|expert_2|psychopathology|DDF|target|women during pregnancy and postpartum|human
30826885|expert_2|gut microbiota|microbiome|is linked to|PMAD|DDF
30826885|expert_2|gut microbiota|microbiome|located in|women during pregnancy and postpartum|human
27793225|expert_2|highly processed, poor quality foods|food|impact|gut microbiota|microbiome
27793225|expert_2|nutrient-rich diet|food|impact|gut microbiota|microbiome
27793225|expert_2|highly processed, poor quality foods|food|influence|mental disorder|DDF
27793225|expert_2|nutrients|food|impact|gut microbiota|microbiome
27793225|expert_2|mental disorders|DDF|target|populations|human
27793225|expert_2|fiber|dietary supplement|impact|gut microbiota|microbiome
24103493|expert_2|excess body weight during and after pregnancy|DDF|affect|offspring overweight|DDF
24103493|expert_2|Excess body weight during pregnancy|DDF|affect|offspring obesity|DDF
24103493|expert_2|excess body weight during and after pregnancy|DDF|affect|obesity|DDF
24103493|expert_2|excess body weight|DDF|affect|type 2 diabetes|DDF
24103493|expert_2|excess body weight|DDF|affect|depression|DDF
24103493|expert_2|excess body weight|DDF|affect|cardiovascular problems|DDF
33967849|expert_4|probiotics|dietary supplement|influence|depression|DDF
33967849|expert_4|probiotics|dietary supplement|influence|anxiety symptoms|DDF
33967849|expert_4|Perinatal Mental Health|DDF|target|Mothers|human
26426677|expert_5|gut microbiota|microbiome|located in|gastrointestinal tract|anatomical location
26426677|expert_5|psychiatric disturbances|DDF|affect|Intestinal inflammation|DDF
26426677|expert_5|intestinal inflammation|DDF|strike|gastrointestinal tract|anatomical location
26426677|expert_5|stress|DDF|affect|Intestinal inflammation|DDF
38401573|expert_2|synaptic proteins|chemical|located in|PFC|anatomical location
38401573|expert_2|arketamine|drug|impact|gut microbiota|microbiome
38401573|expert_2|chronic restrain stress|DDF|target|male mice|animal
38401573|expert_2|prefrontal cortex|anatomical location|located in|male mice|animal
38401573|expert_2|PFC|anatomical location|located in|male mice|animal
38401573|expert_2|gut microbiota|microbiome|is linked to|depression|DDF
38401573|expert_2|microbiome-derived metabolites|chemical|produced by|gut microbiota|microbiome
38401573|expert_2|arketamine|drug|change effect|CRS-induced body weight loss|DDF
38401573|expert_2|arketamine|drug|interact|GluA1|chemical
38401573|expert_2|gut microbiota|microbiome|located in|CRS-exposed mice|animal
38401573|expert_2|arketamine|drug|interact|PSD-95|chemical
38401573|expert_2|microbiome-derived metabolites|chemical|influence|depression|DDF
34908715|expert_2|gut microbiota|microbiome|is linked to|autism|DDF
34908715|expert_2|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
34908715|expert_2|gut microbiota|microbiome|is linked to|anxiety|DDF
34908715|expert_2|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
34908715|expert_2|gut microbiota|microbiome|is linked to|obesity|DDF
34908715|expert_2|gut microbiota|microbiome|is linked to|severe mental illness|DDF
29955222|expert_7|macronutrients|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|carbohydrates|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|plant foods|food|influence|colon cancer|DDF
29955222|expert_7|gut bacteria|bacteria|influence|chronic disease|DDF
29955222|expert_7|plant foods|food|impact|gut bacteria|bacteria
29955222|expert_7|micronutrients|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|phytochemicals|chemical|influence|type 2 diabetes|DDF
29955222|expert_7|vitamins|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|non-nutrient bioactive compounds|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|fiber|chemical|influence|type 2 diabetes|DDF
29955222|expert_7|plant foods|food|influence|chronic disease|DDF
29955222|expert_7|minerals|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|phytochemicals|chemical|impact|gut bacteria|bacteria
29955222|expert_7|gut bacteria|bacteria|influence|type 2 diabetes|DDF
29955222|expert_7|proteins|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|fiber|chemical|influence|colon cancer|DDF
29955222|expert_7|phytochemicals|chemical|influence|colon cancer|DDF
29955222|expert_7|plant foods|food|influence|type 2 diabetes|DDF
29955222|expert_7|fiber|chemical|impact|gut bacteria|bacteria
29955222|expert_7|phytochemicals|chemical|influence|chronic disease|DDF
29955222|expert_7|fats|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|fiber|chemical|influence|chronic disease|DDF
29955222|expert_7|phytochemicals|chemical|impact|mammalian gut microbiota|microbiome
29955222|expert_7|gut bacteria|bacteria|influence|colon cancer|DDF
37291666|expert_3|SCI|DDF|target|patients|human
37291666|expert_3|neurological disruption|DDF|affect|immune, endocrine, and multisystem dysfunction|DDF
26408987|expert_2|probiotics|dietary supplement|influence|chronic-stress-induced depression|DDF
26408987|expert_2|L. helveticus NS8|dietary supplement|influence|anxiety|DDF
26408987|expert_2|L. helveticus NS8|dietary supplement|influence|cognitive dysfunction|DDF
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|OFT|biomedical technique
26408987|expert_2|L. helveticus NS8|dietary supplement|influence|chronic restraint stress-induced behavioral|DDF
26408987|expert_2|gut microbiota|microbiome|is linked to|stress-related disorders|DDF
26408987|expert_2|Chronic stress|DDF|affect|behavioral, cognitive, biochemical, and gut microbiota aberrations|DDF
26408987|expert_2|L. helveticus NS8|dietary supplement|influence|chronic restraint stress depression|DDF
26408987|expert_2|chronic restraint stress depression|DDF|target|rats|animal
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|SPT|biomedical technique
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|OPT|biomedical technique
26408987|expert_2|Lactobacillus helveticus NS8|bacteria|influence|behavioral, cognitive, and biochemical aberrations|DDF
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|biochemical analysis|biomedical technique
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|elevated-plus maze test|biomedical technique
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|object recognition test|biomedical technique
26408987|expert_2|restraint stress|DDF|target|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal
26408987|expert_2|chronic restraint stress|DDF|affect|behavioral, cognitive, and biochemical aberrations|DDF
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|sucrose preference test|biomedical technique
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|object placement test|biomedical technique
26408987|expert_2|L. helveticus NS8|dietary supplement|influence|depression|DDF
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|open-field test|biomedical technique
26408987|expert_2|Adult specific pathogen free (SPF) Sprague-Dawley rats|animal|used by|ORT|biomedical technique
38292207|expert_2|intestinal microbiota|microbiome|located in|humans|human
38292207|expert_2|intestines|anatomical location|located in|dogs|animal
38292207|expert_2|prebiotics|dietary supplement|influence|anxiety disorders|DDF
38292207|expert_2|probiotics|dietary supplement|influence|anxiety disorders|DDF
38292207|expert_2|intestinal microbiota|microbiome|is linked to|anxiety disorders|DDF
38292207|expert_2|canine anxiety disorders|DDF|target|dogs|animal
38292207|expert_2|dysbiosis|DDF|affect|anxiety|DDF
38292207|expert_2|dysbiosis|DDF|affect|mental disorders|DDF
38292207|expert_2|Anxiety disorders|DDF|target|dogs|animal
34311029|expert_5|AD|DDF|is a|neurodegenerative disease|DDF
34311029|expert_5|cognitive impairment|DDF|affect|major accompanying pathological symptom|DDF
34311029|expert_5|Lipids|chemical|located in|aged and Alzheimer's disease (AD) brains|anatomical location
34311029|expert_5|perturbed metabolic function|DDF|affect|AD|DDF
34311029|expert_5|changes in lipid metabolism|DDF|affect|cognitive impairment|DDF
34311029|expert_5|lipid-based nutraceuticals|dietary supplement|influence|AD|DDF
34311029|expert_5|increased oxidative stress|DDF|affect|AD|DDF
34311029|expert_5|lipid-based nutraceuticals|dietary supplement|influence|cognitive impairment|DDF
34311029|expert_5|nutraceuticals|dietary supplement|influence|cognitive decline|DDF
34311029|expert_5|Lipids|chemical|located in|healthy mature brains|anatomical location
34311029|expert_5|beneficial lipids|chemical|produced by|Gut microbiota|microbiome
34836918|expert_4|BMAA|chemical|impact|SFB|bacteria
34836918|expert_4|BMAA|chemical|influence|dopaminergic neuronal loss|DDF
34836918|expert_4|BMAA|chemical|impact|segmented filamentous bacteria|bacteria
34836918|expert_4|BMAA|chemical|influence|gut dysbiosis|DDF
34836918|expert_4|BMAA|chemical|influence|loss of barrier integrity|DDF
34836918|expert_4|BMAA|chemical|influence|motor deficits|DDF
34836918|expert_4|BMAA|chemical|influence|intestinal inflammation|DDF
34836918|expert_4|BMAA|chemical|influence|neuroinflammation|DDF
34836918|expert_4|BMAA|chemical|influence|immune cell migration|DDF
34836918|expert_4|BMAA|chemical|influence|PD pathology|DDF
37900921|expert_5|4EP|chemical|located in|gut epithelium|anatomical location
37900921|expert_5|4EPS|chemical|located in|gut epithelium|anatomical location
37900921|expert_5|4EPS|chemical|influence|anxiety phenotype|DDF
37900921|expert_5|kidney dysfunction|DDF|target|autistic individuals|human
37900921|expert_5|4EP|chemical|influence|increased intestinal permeability|DDF
37900921|expert_5|4EP|chemical|influence|kidney dysfunction|DDF
37900921|expert_5|4-Ethylphenol|chemical|located in|gut|anatomical location
37900921|expert_5|4EP|chemical|located in|gut|anatomical location
37900921|expert_5|brain|anatomical location|located in|mice|animal
37900921|expert_5|neuromodulator|chemical|impact|gut microbiome|microbiome
37900921|expert_5|gut epithelium|anatomical location|located in|autistic individuals|human
37900921|expert_5|gut microbiome|microbiome|is linked to|autism|DDF
37900921|expert_5|4-ethylphenol sulfate|chemical|influence|anxiety phenotype|DDF
37900921|expert_5|4EP|chemical|located in|human brains|anatomical location
37900921|expert_5|4EP|chemical|located in|kidneys|anatomical location
37900921|expert_5|4EPS|chemical|influence|increased intestinal permeability|DDF
37900921|expert_5|4EPS|chemical|located in|kidneys|anatomical location
37900921|expert_5|4EPS|chemical|located in|human brains|anatomical location
37900921|expert_5|4EP|chemical|produced by|gut microbiome|microbiome
37900921|expert_5|anxiety|DDF|target|mice|animal
37900921|expert_5|4EP|chemical|located in|brain|anatomical location
37900921|expert_5|increased intestinal permeability|DDF|target|autistic individuals|human
37900921|expert_5|anxiety phenotype|DDF|target|autistic individuals|human
37900921|expert_5|Gut-microbiome-derived metabolites|chemical|located in|gut|anatomical location
37900921|expert_5|4EPS|chemical|located in|brain|anatomical location
37900921|expert_5|gut microbiome|microbiome|located in|gut|anatomical location
37900921|expert_5|4EPS|chemical|influence|anxiety|DDF
33318317|expert_5|Elderly patients|human|used by|Neuropsychological assessments|biomedical technique
33318317|expert_5|Elderly patients|human|used by|randomized-control trial of mindful awareness practice|biomedical technique
33318317|expert_5|mild cognitive impairment|DDF|target|Elderly patients|human
33318317|expert_5|gut microbiota|microbiome|located in|brain|anatomical location
33318317|expert_5|gut microbes|microbiome|located in|brain|anatomical location
33318317|expert_5|Elderly patients|human|used by|inflammatory markers|biomedical technique
34704023|expert_6|gut microbiome alpha-diversity|DDF|affect|neurological disorders|DDF
28629758|expert_5|Flavobacterium spp.|bacteria|influence|chronic social defeat|DDF
28629758|expert_5|pro-inflammatory variations|DDF|target|socially stressed mice|animal
28629758|expert_5|Turicibacter spp.|bacteria|influence|Social avoidance behaviors|DDF
28629758|expert_5|gut microbiome|microbiome|located in|socially stressed mice|animal
28629758|expert_5|gut microbiota|microbiome|is linked to|chronic social defeat|DDF
28629758|expert_5|gut microbiota|microbiome|located in|male mice|animal
28629758|expert_5|Turicibacter spp.|bacteria|influence|chronic social defeat|DDF
28629758|expert_5|interleukin (IL)-1β|chemical|located in|prefrontal cortex|anatomical location
28629758|expert_5|IL-6|chemical|influence|severe social avoidance behaviors|DDF
28629758|expert_5|gut microbiome|microbiome|is linked to|depression|DDF
28629758|expert_5|interleukin (IL)-1β|chemical|impact|Flavobacterium spp.|bacteria
28629758|expert_5|social avoidance behaviors|DDF|target|socially stressed mice|animal
28629758|expert_5|IL-6|chemical|influence|Social avoidance behaviors|DDF
28629758|expert_5|chronic social defeat|DDF|target|Mice|animal
28629758|expert_5|interleukin (IL)-1β|chemical|influence|severe social avoidance behaviors|DDF
28629758|expert_5|IL-6|chemical|influence|chronic social defeat|DDF
28629758|expert_5|gut microbiota|microbiome|is linked to|social avoidance effects|DDF
28629758|expert_5|severe social avoidance behaviors|DDF|target|Mice|animal
28629758|expert_5|IL-6|chemical|impact|Turicibacter spp.|bacteria
28629758|expert_5|interleukin (IL)-1β|chemical|influence|chronic social defeat|DDF
28629758|expert_5|interleukin (IL)-1β|chemical|impact|Turicibacter spp.|bacteria
28629758|expert_5|interleukin (IL)-1β|chemical|influence|Social avoidance behaviors|DDF
28629758|expert_5|gut microbiome|microbiome|located in|Male C57BL/6 mice|animal
28629758|expert_5|Social avoidance behaviors|DDF|interact|corticosterone|chemical
28629758|expert_5|chronic social defeat|DDF|target|male mice|animal
28629758|expert_5|Flavobacterium spp.|bacteria|influence|severe social avoidance behaviors|DDF
28629758|expert_5|Turicibacter spp.|bacteria|influence|severe social avoidance behaviors|DDF
28629758|expert_5|social avoidance effects|DDF|affect|chronic social defeat|DDF
28629758|expert_5|Social avoidance behaviors|DDF|interact|pro-inflammatory cytokines|chemical
28629758|expert_5|Flavobacterium spp.|bacteria|influence|Social avoidance behaviors|DDF
28629758|expert_5|gut microbiome|microbiome|is linked to|social avoidance behaviors|DDF
28629758|expert_5|social avoidance behaviors|DDF|target|Male C57BL/6 mice|animal
28629758|expert_5|depression|DDF|target|socially stressed mice|animal
28629758|expert_5|IL-6|chemical|located in|prefrontal cortex|anatomical location
28629758|expert_5|gut microbiome|microbiome|is linked to|pro-inflammatory variations|DDF
28629758|expert_5|social avoidance effects|DDF|target|male mice|animal
28629758|expert_5|IL-6|chemical|impact|Flavobacterium spp.|bacteria
36191806|expert_5|depression-like behaviors|DDF|target|Chrna7 knock-out (KO) mice|animal
36191806|expert_5|depression-like behaviors|DDF|target|Chrna7 KO mice|animal
36191806|expert_5|subdiaphragmatic vagus nerve|anatomical location|located in|Chrna7 KO mice|animal
36191806|expert_5|microbes-derived metabolites|chemical|located in|subdiaphragmatic vagus nerve|anatomical location
36191806|expert_5|medial prefrontal cortex|anatomical location|located in|Chrna7 KO mice|animal
36191806|expert_5|Lactobacillus sp. BL302|bacteria|located in|KO + SDV group|animal
36191806|expert_5|mPFC|anatomical location|located in|Chrna7 KO mice|animal
36191806|expert_5|Chrna7 KO mice|animal|used by|SDV|biomedical technique
36191806|expert_5|depression-like phenotypes|DDF|target|Chrna7 knock-out mice|animal
36191806|expert_5|plasma metabolites|chemical|located in|three groups [wild-type (WT) + sham group, KO + sham group, KO + SDV group]|animal
36191806|expert_5|subdiaphragmatic vagus nerve|anatomical location|located in|Chrna7 knock-out mice|animal
36191806|expert_5|Chrna7 KO mice|animal|used by|subdiaphragmatic vagotomy|biomedical technique
36191806|expert_5|several microbiome|microbiome|located in|three groups [wild-type (WT) + sham group, KO + sham group, KO + SDV group]|animal
36191806|expert_5|synaptic proteins|chemical|located in|mPFC|anatomical location
36191806|expert_5|Lactobacillus reuteri|bacteria|located in|KO + SDV group|animal
36191806|expert_5|synaptic proteins|chemical|located in|Chrna7 KO mice|animal
36191806|expert_5|synaptic proteins|chemical|located in|medial prefrontal cortex|anatomical location
36191806|expert_5|plasma metabolites|chemical|impact|several microbiome|microbiome
36191806|expert_5|abnormal composition of gut microbiota|DDF|target|Chrna7 KO mice|animal
36191806|expert_5|systemic inflammation|DDF|target|Chrna7 knock-out (KO) mice|animal
36191806|expert_5|Lactobacillus hominis|bacteria|located in|KO + SDV group|animal
36191806|expert_5|abnormal composition of gut microbiota|DDF|target|Chrna7 knock-out (KO) mice|animal
37485386|expert_3|GOS|dietary supplement|influence|depressive symptoms|DDF
37485386|expert_3|eicosapentaenoic acid|chemical|influence|depressive symptoms|DDF
37485386|expert_3|prebiotics|dietary supplement|influence|depression|DDF
37485386|expert_3|Prebiotics|dietary supplement|influence|depression|DDF
33936013|expert_6|i>Bacteroides thetaiotaomicron</i> DSM 2079|bacteria|influence|acid-induced cellular damage|DDF
33936013|expert_6|intestinal <i>Bacteroides</i>|bacteria|interact|GABA|chemical
33467657|expert_6|overnutrition|DDF|target|offspring|human
33467657|expert_6|maternal obesity|DDF|target|offspring|human
33467657|expert_6|Cognitive and Behavioural Effects|DDF|affect|Maternal Obesity|DDF
33467657|expert_6|maternal overnutrition|DDF|affect|dysregulated brain hormones|DDF
33467657|expert_6|gut microbiota|microbiome|is linked to|obesity-induced changes|DDF
33467657|expert_6|maternal overnutrition|DDF|affect|disrupted neuronal circuities and connectivity|DDF
33467657|expert_6|neuroinflammation|DDF|change abundance|gut microbiome|microbiome
33467657|expert_6|maternal overnutrition|DDF|affect|neuroinflammation|DDF
36707651|expert_2|serotonin|chemical|impact|gut microbiota|microbiome
36707651|expert_2|gut microbiota|microbiome|is linked to|psychiatric disorder|DDF
36707651|expert_2|psychiatric drugs|drug|impact|gut microbiota|microbiome
36707651|expert_2|gut microbiota|microbiome|is linked to|BD|DDF
36707651|expert_2|gut microbiota|microbiome|located in|BD patients|human
36707651|expert_2|gut microbiota|microbiome|located in|patients|human
36707651|expert_2|gut microbiota|microbiome|is linked to|neuroinflammation|DDF
36707651|expert_2|gut microbiota|microbiome|is linked to|intestinal, systemic and brain inflammation|DDF
34589852|expert_6|altered gut microbiota|microbiome|is linked to|nutritional deficits|DDF
34589852|expert_6|nutritional deficits|DDF|affect|inflammation and immune dysregulation|DDF
34589852|expert_6|altered gut microbiota|microbiome|is linked to|inflammation and immune dysregulation|DDF
34589852|expert_6|schizophrenia-spectrum disorders|DDF|target|patients|human
34589852|expert_6|psychotropic medication|drug|change effect|schizophrenia-spectrum disorders|DDF
37764088|expert_2|Altered Gut Microbiota Composition|DDF|affect|Difficulty in Explicit Emotion Regulation|DDF
37764088|expert_2|Actinomyces|bacteria|part of|GM|microbiome
37764088|expert_2|Sutterella|bacteria|part of|GM|microbiome
37764088|expert_2|GM|microbiome|is linked to|physical and mental problems|DDF
37764088|expert_2|Gut microbiota|microbiome|is linked to|physical and mental problems|DDF
37764088|expert_2|children aged 3-4|human|used by|16S rRNA gene sequencing|biomedical technique
37764088|expert_2|GM|microbiome|located in|children aged 3-4|human
37764088|expert_2|GM|microbiome|used by|16S rRNA gene sequencing|biomedical technique
37764088|expert_2|Difficulty in Explicit Emotion Regulation|DDF|target|Young Children|human
31255682|expert_1|gut microbiota|microbiome|is linked to|schizophrenia|DDF
31255682|expert_1|schizophrenia|DDF|target|patients|human
31255682|expert_1|sex- and age-matched healthy controls|human|used by|Shotgun metagenomic sequencing|biomedical technique
31255682|expert_1|sex- and age-matched healthy controls|human|used by|16S rRNA sequencing|biomedical technique
31255682|expert_1|schizophrenia|DDF|target|Patients|human
31255682|expert_1|patients|human|used by|Shotgun metagenomic sequencing|biomedical technique
31255682|expert_1|patients|human|used by|16S rRNA sequencing|biomedical technique
38432867|expert_4|Disordered gut microbiota|microbiome|is linked to|TAO|DDF
38432867|expert_4|gut microbiota|microbiome|is linked to|TAO|DDF
35565918|expert_4|neurological problems|DDF|target|patients|human
33076930|expert_2|constipation|DDF|is a|Gastrointestinal tract dysfunction|DDF
33076930|expert_2|C. sporogenes|bacteria|interact|levodopa|drug
33076930|expert_2|Gastrointestinal tract dysfunction|DDF|affect|Parkinson's disease|DDF
33076930|expert_2|gut bacterium C. sporogenes|bacteria|part of|gut microbiota|microbiome
33076930|expert_2|3-(3,4-dihydroxyphenyl)propionic acid|chemical|produced by|gut microbiota|microbiome
33076930|expert_2|Parkinson's disease|DDF|is a|progressive neurodegenerative disorder|DDF
33076930|expert_2|levodopa|drug|change effect|Parkinson's disease|DDF
33076930|expert_2|constipation|DDF|affect|Parkinson's disease|DDF
33076930|expert_2|PD|DDF|is a|progressive neurodegenerative disorder|DDF
30258234|expert_5|Injury to neurons|DDF|affect|Parkinson's|DDF
30258234|expert_5|Injury to neurons|DDF|affect|amyotrophic lateral sclerosis|DDF
30258234|expert_5|Injury to neurons|DDF|affect|Huntington's|DDF
30258234|expert_5|Injury to neurons|DDF|affect|Alzheimer's|DDF
30258234|expert_5|Injury to neurons|DDF|affect|frontotemporal dementia|DDF
30258234|expert_5|neuroinflammation|DDF|affect|Injury to neurons|DDF
30258234|expert_5|disruption of the sentinel or housekeeping functions|DDF|affect|Injury to neurons|DDF
30258234|expert_5|dysregulation of the defense function|DDF|affect|Injury to neurons|DDF
30258234|expert_5|Injury to neurons|DDF|affect|chronic traumatic encephalopathy|DDF
30258234|expert_5|gut microbiome|microbiome|is linked to|neurodegeneration|DDF
33963284|expert_4|(R,S)-ketamine|drug|interact|N-methyl-D-aspartate receptor|chemical
33963284|expert_4|esketamine|drug|change effect|treatment-resistant depression|DDF
33963284|expert_4|(R,S)-ketamine|drug|interact|NMDAR|chemical
33963284|expert_4|arketamine|drug|interact|NMDAR|chemical
33963284|expert_4|depression|DDF|target|patients|human
32518376|expert_4|synaptic proteins|chemical|located in|mPFC|anatomical location
32518376|expert_4|LPS|chemical|influence|inflammation|DDF
32518376|expert_4|synaptic proteins|chemical|located in|medial prefrontal cortex|anatomical location
32518376|expert_4|gut microbiota|microbiome|located in|mice|animal
32518376|expert_4|medial prefrontal cortex|anatomical location|located in|sham-operated mice|animal
32518376|expert_4|lipopolysaccharide|chemical|impact|gut microbiota|microbiome
32518376|expert_4|LPS|chemical|impact|gut microbiota|microbiome
32518376|expert_4|mPFC|anatomical location|located in|sham-operated mice|animal
32819434|expert_3|gut microbiota|microbiome|change expression|EPHB6|gene
32819434|expert_3|gut microbiota|microbiome|is linked to|autism-like behavior|DDF
32819434|expert_3|autism-like behavior|DDF|target|wild-type mice|animal
32819434|expert_3|fecal microbiota|microbiome|located in|EphB6-deficient mice|animal
32819434|expert_3|gut microbiota|microbiome|is linked to|brain dysfunctions|DDF
32819434|expert_3|ASD|DDF|target|patients|human
32819434|expert_3|gut microbiota|microbiome|located in|mice|animal
32819434|expert_3|gut microbiota|microbiome|located in|EphB6-deficient mice|animal
32819434|expert_3|autism-like behavior|DDF|target|EphB6-deficient mice|animal
32819434|expert_3|gut microbiota|microbiome|is linked to|autism-like social behavior|DDF
34576000|expert_7|host gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
34576000|expert_7|Parkinson's disease|DDF|target|elderly individuals|human
34576000|expert_7|Gut Microbiome|microbiome|is linked to|Parkinson's Disease|DDF
34576000|expert_7|PD|DDF|target|elderly individuals|human
34576000|expert_7|Parkinson's disease|DDF|target|PD patients|human
34576000|expert_7|Gut Microbiome|microbiome|is linked to|PD|DDF
34576000|expert_7|host gut microbiome|microbiome|is linked to|PD|DDF
34576000|expert_7|PD|DDF|target|PD patients|human
34576000|expert_7|neurodegenerative disorder|DDF|target|elderly individuals|human
34576000|expert_7|host gut microbiome|microbiome|located in|PD patients|human
34576000|expert_7|Gut Microbiome|microbiome|is linked to|Parkinson's disease|DDF
38247868|expert_5|psychiatric manifestations of IBD|DDF|target|IBD patients|human
38247868|expert_5|Psychiatric Comorbidities|DDF|affect|Inflammatory Bowel Disease|DDF
38247868|expert_5|Crohn's disease|DDF|is a|Inflammatory bowel disease|DDF
38247868|expert_5|IBD-associated comorbidities|DDF|target|IBD patients|human
38247868|expert_5|ulcerative colitis|DDF|is a|Inflammatory bowel disease|DDF
38247868|expert_5|IBD|DDF|target|IBD patients|human
38247868|expert_5|brain|anatomical location|located in|IBD patients|human
38247868|expert_5|Psychiatric comorbidities|DDF|target|IBD patients|human
38247868|expert_5|Crohn's disease|DDF|is a|IBD|DDF
38247868|expert_5|Psychiatric comorbidities|DDF|affect|Inflammatory bowel disease|DDF
38247868|expert_5|depression|DDF|target|IBD patients|human
38247868|expert_5|ulcerative colitis|DDF|is a|IBD|DDF
38247868|expert_5|anxiety|DDF|is a|Psychiatric comorbidities|DDF
38247868|expert_5|Inflammatory bowel disease|DDF|affect|chronic, relapse-remitting condition|DDF
38247868|expert_5|Inflammatory bowel disease|DDF|strike|gastrointestinal tract|anatomical location
38247868|expert_5|neuroinflammation|DDF|target|IBD patients|human
38247868|expert_5|anxiety|DDF|target|IBD patients|human
38247868|expert_5|Inflammatory bowel disease|DDF|target|IBD patients|human
38247868|expert_5|Psychiatric comorbidities|DDF|affect|IBD|DDF
38247868|expert_5|depression|DDF|is a|Psychiatric comorbidities|DDF
34357554|expert_2|neurodegeneration|DDF|is a|CNS pathologies|DDF
34357554|expert_2|gut microbiota|microbiome|is linked to|neurodegenerative disorders|DDF
31154909|expert_2|BCM-7|chemical|influence|obesity|DDF
31154909|expert_2|beta-casomorphin-7|chemical|interact|A1 beta-casein|chemical
31154909|expert_2|BCM-7|chemical|influence|type 1 diabetes|DDF
31154909|expert_2|BCM-7|chemical|influence|cardiovascular diseases|DDF
31154909|expert_2|bovine milk|food|influence|cardiovascular diseases|DDF
31154909|expert_2|bioactive peptides|chemical|influence|cardiovascular diseases|DDF
31154909|expert_2|μ-opioid receptors|chemical|influence|gut inflammation|DDF
31154909|expert_2|bioactive peptides|chemical|influence|type 1 diabetes|DDF
31154909|expert_2|beta-casomorphin-7|chemical|influence|type 1 diabetes|DDF
31154909|expert_2|beta-casomorphin-7|chemical|influence|cardiovascular diseases|DDF
31154909|expert_2|BCM-7|chemical|influence|fractures|DDF
31154909|expert_2|bovine milk|food|influence|type 1 diabetes|DDF
28442250|expert_5|fecal microbiota|microbiome|located in|FEP patients|human
28442250|expert_5|Lactobacillus group bacteria|bacteria|influence|first-episode psychosis|DDF
28442250|expert_5|mental disorders|DDF|target|patients|human
28442250|expert_5|fecal microbiota|microbiome|located in|healthy matched controls|human
28442250|expert_5|psychotic illness|DDF|target|patients|human
28442250|expert_5|fecal microbiota|microbiome|is linked to|psychotic illness|DDF
28442250|expert_5|Lactobacillus group bacteria|bacteria|part of|fecal microbiota|microbiome
28442250|expert_5|gut microbiota|microbiome|is linked to|microbiota alterations|DDF
28442250|expert_5|microbiota alterations|DDF|affect|psychotic illness|DDF
28442250|expert_5|fecal microbiota|microbiome|is linked to|FEP|DDF
28442250|expert_5|fecal microbiota|microbiome|is linked to|mental disorders|DDF
28442250|expert_5|Lactobacillus group bacteria|bacteria|influence|FEP|DDF
28442250|expert_5|gut microbiota|microbiome|is linked to|psychotic illness|DDF
28442250|expert_5|first-episode psychosis|DDF|target|patients|human
28442250|expert_5|FEP|DDF|target|patients|human
28442250|expert_5|fecal microbiota|microbiome|located in|patients|human
28442250|expert_5|fecal microbiota|microbiome|located in|FEP-patients|human
28442250|expert_5|gut microbiota|microbiome|is linked to|mental disorders|DDF
28442250|expert_5|fecal microbiota|microbiome|is linked to|first-episode psychosis|DDF
28442250|expert_5|fecal microbiota|microbiome|is linked to|microbiota alterations|DDF
30701194|expert_7|autism spectrum disorders|DDF|target|ASD group|human
30701194|expert_7|typical development|DDF|target|TD group|human
30701194|expert_7|Autism Spectrum Disorder|DDF|target|children|human
30701194|expert_7|typical development|DDF|target|age-matched children|human
30701194|expert_7|TD|DDF|target|TD group|human
30701194|expert_7|Eggerthella lenta|bacteria|located in|ASD group|human
30701194|expert_7|ASD|DDF|target|Children|human
30701194|expert_7|Bacteroides vulgatus|bacteria|located in|ASD group|human
30701194|expert_7|TD|DDF|target|age-matched children|human
30701194|expert_7|ASD|DDF|target|children|human
30701194|expert_7|gut microbiota|microbiome|located in|children|human
30701194|expert_7|children|human|used by|gut metagenomic and metabolome study|biomedical technique
30701194|expert_7|gut 2-keto-glutaramic acid|chemical|influence|ASD|DDF
30701194|expert_7|ASD|DDF|target|ASD group|human
30701194|expert_7|gut microbiota|microbiome|is linked to|Autism Spectrum Disorder|DDF
30701194|expert_7|Clostridium botulinum|bacteria|located in|ASD group|human
30701194|expert_7|glutamate metabolites|chemical|located in|ASD group|human
30701194|expert_7|autism spectrum disorders|DDF|target|children|human
30701194|expert_7|gut microbiota|microbiome|is linked to|ASD|DDF
30701194|expert_7|Autism Spectrum Disorder|DDF|target|Children|human
30701194|expert_7|2-keto-glutaramic acid|chemical|located in|ASD group|human
34988495|expert_6|gut microbiome|microbiome|is linked to|trauma- and stressor-related disorders|DDF
34988495|expert_6|gut microbiome|microbiome|is linked to|posttraumatic stress disorder|DDF
34988495|expert_6|PVD|DDF|affect|severe depression|DDF
34988495|expert_6|PVD|DDF|affect|cardiovascular disease|DDF
34988495|expert_6|bipolar disorders|DDF|affect|severe depression|DDF
34988495|expert_6|gut microbiome|microbiome|located in|Veterans|human
34988495|expert_6|peripheral vascular disease|DDF|affect|severe depression|DDF
34988495|expert_6|gastroenteritis|DDF|affect|severe depression|DDF
34988495|expert_6|gut microbiota|microbiome|located in|Veterans|human
34988495|expert_6|gut microbiome|microbiome|is linked to|affective disorders|DDF
34988495|expert_6|gut microbiome|microbiome|is linked to|anxiety disorders|DDF
34988495|expert_6|gut microbiome|microbiome|is linked to|PTSD|DDF
34988495|expert_6|PTSD|DDF|target|male|human
34988495|expert_6|gut microbiota|microbiome|is linked to|chronic health conditions|DDF
34988495|expert_6|gut microbiome|microbiome|located in|United States (US) military Veterans|human
34988495|expert_6|traumatic brain injuries|DDF|target|male|human
32890382|expert_6|epigenetic processes|DDF|affect|traumatic or stress events|DDF
32890382|expert_6|neurophysiological, inflammatory or hypothalamic-pituitary-adrenal axis dysregulations|DDF|affect|psychological stress|DDF
32890382|expert_6|gut microbiota|microbiome|is linked to|epigenetic processes|DDF
32890382|expert_6|epigenetic processes|DDF|affect|psychiatric disorders|DDF
32890382|expert_6|gut microbiota|microbiome|is linked to|inflammatory response|DDF
32890382|expert_6|gut microbiota|microbiome|is linked to|traumatic or stress events|DDF
34147969|expert_2|Faecalibaculum rodentium|bacteria|influence|anhedonia-like behavior|DDF
34147969|expert_2|CSDS|DDF|target|Ephx2 knock-out (KO) mice|animal
34147969|expert_2|anhedonia-like behavior|DDF|target|ABX-treated WT and Ephx2 KO mice|animal
34147969|expert_2|F. rodentium|bacteria|influence|anhedonia-like behavior|DDF
34147969|expert_2|F. rodentium|bacteria|influence|depression- and anhedonia-like behaviors|DDF
34147969|expert_2|F. rodentium|bacteria|interact|synaptic proteins|chemical
34147969|expert_2|F. rodentium|bacteria|interact|interleukin-6|chemical
34147969|expert_2|inflammation|DDF|affect|stress-related depression|DDF
34147969|expert_2|Soluble epoxide hydrolase|chemical|influence|inflammation|DDF
34147969|expert_2|chronic social defeat stress|DDF|target|Ephx2 knock-out (KO) mice|animal
37624502|expert_4|Bifidobacterium longum|bacteria|part of|gut microbiota|microbiome
36056574|expert_7|sleep disturbance|DDF|target|participants|human
36056574|expert_7|GM|microbiome|located in|Asian Americans|human
36056574|expert_7|depressive symptoms|DDF|target|Chinese and Korean immigrants|human
36056574|expert_7|sleep disturbance|DDF|target|AsA|human
36056574|expert_7|GM|microbiome|is linked to|depressive symptoms|DDF
36056574|expert_7|gut microbiota|microbiome|located in|Asian Americans|human
36056574|expert_7|Gut Microbiota|microbiome|is linked to|sleep disturbance|DDF
36056574|expert_7|depressive symptoms|DDF|change abundance|Actinobacteria|bacteria
36056574|expert_7|GM|microbiome|located in|AsA|human
36056574|expert_7|depressive symptoms|DDF|target|Chinese and Korean American immigrants|human
36056574|expert_7|gut microbiota|microbiome|located in|AsA|human
36056574|expert_7|sleep disturbance|DDF|target|Asian Americans|human
36056574|expert_7|Depression|DDF|target|population|human
36056574|expert_7|sleep disturbance|DDF|target|Chinese and Korean immigrants|human
36056574|expert_7|GM|microbiome|located in|Chinese and Korean American immigrants|human
36056574|expert_7|depression|DDF|target|AsA|human
36056574|expert_7|sleep disturbance|DDF|target|Chinese and Korean American immigrants|human
36056574|expert_7|Gut Microbiota|microbiome|located in|Chinese and Korean American immigrants|human
36056574|expert_7|Sleep Disturbance|DDF|target|Chinese and Korean Immigrants|human
36056574|expert_7|depression|DDF|target|Asian Americans|human
36056574|expert_7|Gut Microbiota|microbiome|is linked to|Sleep Disturbance|DDF
36056574|expert_7|depression|DDF|affect|sleep disturbance|DDF
36056574|expert_7|Depressive Symptoms|DDF|target|Chinese and Korean Immigrants|human
36056574|expert_7|sleep disturbance|DDF|target|population|human
36056574|expert_7|depressive symptoms|DDF|affect|sleep disturbance|DDF
36056574|expert_7|GM|microbiome|located in|population|human
36056574|expert_7|Depression|DDF|target|Asian Americans|human
36056574|expert_7|Gut Microbiota|microbiome|is linked to|Depressive Symptoms|DDF
36056574|expert_7|Depression|DDF|target|AsA|human
36056574|expert_7|depressive symptoms|DDF|target|participants|human
36056574|expert_7|Gut Microbiota|microbiome|is linked to|depressive symptoms|DDF
36056574|expert_7|depression|DDF|target|population|human
36056574|expert_7|Gut Microbiota|microbiome|located in|Chinese and Korean Immigrants|human
36056574|expert_7|GM|microbiome|is linked to|sleep disturbance|DDF
36056574|expert_7|GM|microbiome|located in|participants|human
33514545|expert_6|microbiome-associated short-chain fatty acids|chemical|influence|PD|DDF
31750916|expert_5|inflammatory compounds|chemical|influence|depression|DDF
31750916|expert_5|microbiota-driven modification of gene expression|DDF|affect|depression|DDF
31750916|expert_5|dietary fiber|dietary supplement|influence|depression|DDF
31750916|expert_5|dietary fiber|dietary supplement|influence|inflammatory and depressive disorders|DDF
31750916|expert_5|Dietary fiber|dietary supplement|influence|depression|DDF
31750916|expert_5|Dietary fiber|dietary supplement|influence|inflammation|DDF
31750916|expert_5|increased production of neurotransmitters|DDF|affect|depression|DDF
31750916|expert_5|Dietary fiber|dietary supplement|impact|gut microbiota|microbiome
31750916|expert_5|gut microbiota|microbiome|located in|gut|anatomical location
31750916|expert_5|inflammation|DDF|affect|depression|DDF
31750916|expert_5|dietary fiber|dietary supplement|influence|increased production of neurotransmitters|DDF
31750916|expert_5|dietary fiber|dietary supplement|influence|microbiota-driven modification of gene expression|DDF
31750916|expert_5|high-fiber diet|food|influence|inflammation|DDF
34074025|expert_2|dysbiosis|DDF|affect|chronic diseases|DDF
34074025|expert_2|Dysfunction of MAIT cells|DDF|affect|chronic diseases|DDF
34074025|expert_2|Multiple Sclerosis|DDF|is a|Autoimmune Diseases|DDF
34074025|expert_2|autoimmune disorders|DDF|change abundance|gut microbiota|microbiome
34074025|expert_2|multiple sclerosis|DDF|change abundance|gut microbiota|microbiome
24956966|expert_3|gut microbiota|microbiome|is linked to|mental health outcomes|DDF
30528936|expert_3|ketamine|drug|impact|gut microbiota|microbiome
30528936|expert_3|Coriobacteriia|bacteria|influence|immobility|DDF
30528936|expert_3|Actinobacteria|bacteria|influence|immobility|DDF
30528936|expert_3|Ketamine|drug|change effect|immobility time|DDF
37995475|expert_2|narcolepsy type 1|DDF|target|patients|human
37995475|expert_2|narcolepsy type 2|DDF|target|patients|human
37995475|expert_2|gut microbiota|microbiome|is linked to|sleep disorders|DDF
37995475|expert_2|idiopathic hypersomnia|DDF|target|patients|human
37995475|expert_2|gut microbiota|microbiome|located in|patients|human
38278499|expert_2|major depressive disorder|DDF|target|individuals|human
38278499|expert_2|major depressive disorder|DDF|interact|hippuric acid|chemical
38278499|expert_2|MDD|DDF|target|individuals|human
38278499|expert_2|GP|human|used by|targeted liquid chromatography mass spectrometry method|biomedical technique
38278499|expert_2|non-depressed general population|human|used by|targeted liquid chromatography mass spectrometry method|biomedical technique
38278499|expert_2|depression|DDF|target|persons|human
38278499|expert_2|individuals|human|used by|targeted liquid chromatography mass spectrometry method|biomedical technique
38278499|expert_2|hippuric acid|chemical|influence|Alcohol use-associated alterations|DDF
38278499|expert_2|Alcohol use-associated alterations|DDF|affect|depression|DDF
38679353|expert_4|PD|DDF|change abundance|Prevotellaceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Rikenellaceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Verrucomicrobiaceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Ruminococcaceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Lachnospiraceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Faecalibacterium|bacteria
38679353|expert_4|PD|DDF|change abundance|Christensenellaceae|bacteria
38679353|expert_4|gut microbiome|microbiome|is linked to|PD|DDF
38679353|expert_4|PD|DDF|change abundance|Bifidobacteriaceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Lactobacillaceae|bacteria
38679353|expert_4|PD|DDF|change abundance|Erysipelotrichaceae|bacteria
38664425|expert_5|neuronal damage|DDF|affect|NDDs|DDF
38664425|expert_5|progressive loss of neuron function|DDF|affect|Neurodegenerative diseases|DDF
38664425|expert_5|progressive loss of neuron function|DDF|affect|NDDs|DDF
38664425|expert_5|neuronal damage|DDF|affect|Neurodegenerative diseases|DDF
33454868|expert_6|gut microbiome|microbiome|is linked to|cancer|DDF
33454868|expert_6|bacteria|bacteria|influence|breast cancer|DDF
33454868|expert_6|intestinal microbes|microbiome|is linked to|breast cancer|DDF
33454868|expert_6|Breast cancer|DDF|target|women|human
33454868|expert_6|cancer|DDF|target|women|human
33454868|expert_6|gut microbiota|microbiome|is linked to|breast cancer|DDF
33454868|expert_6|gut microbiome|microbiome|is linked to|diabetes|DDF
31498131|expert_6|atypical parkinsonism cohorts|human|used by|measurements of fecal microbial concentrations|biomedical technique
31498131|expert_6|prodromal and treatment-naïve de novo PD subjects|human|used by|multi-omics assessments|biomedical technique
31498131|expert_6|gut microbiome|microbiome|is linked to|PD|DDF
31498131|expert_6|Gut microbiota|microbiome|is linked to|PD|DDF
31498131|expert_6|Gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
31498131|expert_6|prodromal and treatment-naïve de novo PD subjects|human|used by|measurements of fecal microbial concentrations|biomedical technique
31498131|expert_6|atypical parkinsonism cohorts|human|used by|multi-omics assessments|biomedical technique
33782648|expert_5|neurodegenerative diseases|DDF|target|patients|human
33782648|expert_5|Fisetin|chemical|influence|traumatic brain injury|DDF
33782648|expert_5|stroke (both ischemic and hemorrhagic)|DDF|is a|neurological disorders|DDF
33782648|expert_5|Fisetin|chemical|influence|neurological disorders|DDF
33782648|expert_5|Fisetin|chemical|influence|Alzheimer's disease|DDF
33782648|expert_5|traumatic brain injury|DDF|is a|neurological disorders|DDF
33782648|expert_5|Alzheimer's disease|DDF|is a|neurological disorders|DDF
33782648|expert_5|Flavonol Fisetin|chemical|influence|Neurological Disorders|DDF
33782648|expert_5|neurodegenerative diseases|DDF|target|aging population|human
33782648|expert_5|Fisetin|chemical|influence|amyotrophic lateral sclerosis|DDF
33782648|expert_5|Neurological disorders|DDF|target|patients|human
33782648|expert_5|Fisetin|chemical|influence|brain dysfunction|DDF
33782648|expert_5|brain dysfunction|DDF|target|humans|human
33782648|expert_5|amyotrophic lateral sclerosis|DDF|is a|neurological disorders|DDF
33782648|expert_5|Fisetin|chemical|influence|Parkinson's disease|DDF
33782648|expert_5|Parkinson's disease|DDF|is a|neurological disorders|DDF
33782648|expert_5|Neurological disorders|DDF|target|aging population|human
33782648|expert_5|Fisetin|chemical|influence|stroke (both ischemic and hemorrhagic)|DDF
33782648|expert_5|Fisetin|chemical|influence|Huntington's disease|DDF
33782648|expert_5|gut microbiome|microbiome|is linked to|neurological disorders|DDF
33782648|expert_5|Huntington's disease|DDF|is a|neurological disorders|DDF
33782648|expert_5|disruptions in multiple cellular systems|DDF|affect|neurological disorders|DDF
32739746|expert_6|dysregulation of CORT production|DDF|affect|acute stress|DDF
32739746|expert_6|endocannabinoid N-arachidonoylethanolamide|chemical|influence|anxiety-like behavior|DDF
32739746|expert_6|C. albicans|bacteria|influence|anxiety-like behavior|DDF
32739746|expert_6|AEA|chemical|influence|anxiety-like behavior|DDF
32739746|expert_6|gut microbiota|microbiome|located in|mice|animal
32739746|expert_6|commensal fungus Candida albicans|bacteria|influence|dysregulation of endocannabinoid signaling|DDF
33860090|expert_7|Probiotic supplementation|dietary supplement|influence|intestinal inflammation|DDF
33860090|expert_7|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
33860090|expert_7|probiotics|dietary supplement|influence|Parkinson's disease|DDF
33860090|expert_7|Probiotic supplementation|dietary supplement|influence|inflammation|DDF
33860090|expert_7|Probiotics|dietary supplement|influence|Parkinson's disease|DDF
33860090|expert_7|dysbiosis|DDF|affect|Parkinson's disease|DDF
33860090|expert_7|intestinal inflammation|DDF|affect|PD|DDF
33860090|expert_7|constipation|DDF|affect|PD|DDF
33860090|expert_7|probiotics|dietary supplement|impact|gut microbiome|microbiome
33860090|expert_7|fecal short-chain fatty acids|chemical|influence|PD|DDF
33860090|expert_7|probiotics|dietary supplement|influence|dopaminergic neuronal degeneration|DDF
33860090|expert_7|constipation|DDF|affect|Parkinson's disease|DDF
33860090|expert_7|probiotics|dietary supplement|influence|motor disability|DDF
33860090|expert_7|Probiotic supplementation|dietary supplement|impact|gut microbiome|microbiome
33860090|expert_7|probiotics|dietary supplement|influence|intestinal inflammation|DDF
33860090|expert_7|fecal short-chain fatty acids|chemical|influence|Parkinson's disease|DDF
33860090|expert_7|intestinal inflammation|DDF|affect|Parkinson's disease|DDF
33860090|expert_7|dysbiosis|DDF|affect|PD|DDF
33860090|expert_7|gut microbiome|microbiome|is linked to|PD|DDF
33860090|expert_7|dysbiosis|DDF|affect|peripheral inflammatory states|DDF
33860090|expert_7|probiotics|dietary supplement|influence|PD|DDF
33860090|expert_7|probiotics|dietary supplement|influence|constipation|DDF
33240722|expert_4|gut microbiome|microbiome|is linked to|CNS disorders|DDF
33240722|expert_4|gut microbiome|microbiome|is linked to|neurodevelopmental and neurodegenerative disorders|DDF
38302874|expert_5|mucosa associated microbiota|microbiome|is linked to|PIPO|DDF
38302874|expert_5|mucosa associated microbiota|microbiome|used by|next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16 S|biomedical technique
38302874|expert_5|duodenum|anatomical location|located in|age-/sex-matched healthy controls|human
38302874|expert_5|Pediatric chronic intestinal pseudo-obstruction|DDF|target|PIPO patients|human
38302874|expert_5|MAM|microbiome|used by|next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16 S|biomedical technique
38302874|expert_5|5-HT|chemical|impact|Gut microbiota|microbiome
38302874|expert_5|age-/sex-matched healthy controls|human|used by|DNA extraction|biomedical technique
38302874|expert_5|PIPO patients|human|used by|qPCR|biomedical technique
38302874|expert_5|gut microbiota|microbiome|is linked to|Chronic intestinal pseudo-obstruction|DDF
38302874|expert_5|specific MAM associated to underlying pathology|microbiome|is linked to|altered intestinal serotonin pathway|DDF
38302874|expert_5|MAM|microbiome|used by|DNA extraction|biomedical technique
38302874|expert_5|5-HT|chemical|impact|gut microbiota|microbiome
38302874|expert_5|dysfunction of the serotonin pathway, possibly related to or triggered by an altered microbiota|DDF|target|PIPO patients|human
38302874|expert_5|mucosa associated microbiota|microbiome|used by|DNA extraction|biomedical technique
38302874|expert_5|PIPO patients|human|used by|next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16 S|biomedical technique
38302874|expert_5|neurotransmitter 5-hydroxytryptamine|chemical|impact|Gut microbiota|microbiome
38302874|expert_5|extremely severe impairment of propulsive motility|DDF|affect|PIPO|DDF
38302874|expert_5|MAM|microbiome|is linked to|PIPO|DDF
38302874|expert_5|MAM|microbiome|is linked to|dysbiosis|DDF
38302874|expert_5|specific MAM associated to underlying pathology|microbiome|located in|PIPO patients|human
38302874|expert_5|colon|anatomical location|located in|PIPO patients|human
38302874|expert_5|ileum|anatomical location|located in|PIPO patients|human
38302874|expert_5|symptoms and radiological signs suggestive of intestinal obstruction|DDF|affect|Pediatric chronic intestinal pseudo-obstruction|DDF
38302874|expert_5|5-HT|chemical|influence|PIPO|DDF
38302874|expert_5|controls|human|used by|qPCR|biomedical technique
38302874|expert_5|PIPO patients|human|used by|DNA extraction|biomedical technique
38302874|expert_5|dysmotility|DDF|target|PIPO patients|human
38302874|expert_5|neurotransmitter 5-hydroxytryptamine|chemical|influence|PIPO|DDF
38302874|expert_5|MAM|microbiome|located in|PIPO patients|human
38302874|expert_5|duodenum|anatomical location|located in|PIPO patients|human
38302874|expert_5|serotonin|chemical|influence|PIPO|DDF
38302874|expert_5|dysbiosis|DDF|target|PIPO patients|human
38302874|expert_5|gut microbiota|microbiome|is linked to|PIPO|DDF
38302874|expert_5|ileum|anatomical location|located in|age-/sex-matched healthy controls|human
38302874|expert_5|altered intestinal serotonin pathway|DDF|target|PIPO patients|human
38302874|expert_5|PIPO|DDF|target|PIPO patients|human
38302874|expert_5|age-/sex-matched healthy controls|human|used by|qPCR|biomedical technique
38302874|expert_5|MAM|microbiome|located in|controls|human
38302874|expert_5|dysfunction of the serotonin pathway, possibly related to or triggered by an altered microbiota|DDF|affect|dysmotility|DDF
38302874|expert_5|symptoms and radiological signs suggestive of intestinal obstruction|DDF|affect|PIPO|DDF
38302874|expert_5|colon|anatomical location|located in|age-/sex-matched healthy controls|human
38302874|expert_5|age-/sex-matched healthy controls|human|used by|next generation sequencing (NGS) of the V3-V4 region of the bacterial RNA 16 S|biomedical technique
38302874|expert_5|extremely severe impairment of propulsive motility|DDF|affect|Pediatric chronic intestinal pseudo-obstruction|DDF
38302874|expert_5|serotonin|chemical|impact|Gut microbiota|microbiome
38229613|expert_4|Parkinson's Disease|DDF|target|Patients|human
38229613|expert_4|Parkinson's disease|DDF|change abundance|Fusicatenibacter|bacteria
38229613|expert_4|healthy controls|human|used by|Full-length bacterial 16S rRNA gene sequencing|biomedical technique
38229613|expert_4|Parkinson's disease|DDF|change abundance|Coriobacteriaceae|bacteria
38229613|expert_4|gut microbiota|microbiome|used by|Full-length bacterial 16S rRNA gene sequencing|biomedical technique
38229613|expert_4|Parkinson's disease|DDF|change abundance|Cristensenellaceae|bacteria
38229613|expert_4|Parkinson's disease|DDF|change abundance|Clostridia UCG 014|bacteria
38229613|expert_4|Parkinson's disease|DDF|change abundance|Oscillospiraceae|bacteria
38229613|expert_4|HCs|human|used by|Full-length bacterial 16S rRNA gene sequencing|biomedical technique
38229613|expert_4|PD|DDF|change abundance|Bacteroides|bacteria
38229613|expert_4|PD|DDF|change abundance|Clostridia UCG 014|bacteria
38229613|expert_4|Parkinson's disease|DDF|change abundance|Blautia|bacteria
38229613|expert_4|Parkinson's disease|DDF|change abundance|Lachinospiracea|bacteria
38229613|expert_4|PD|DDF|change abundance|Lachnospiraceae NK4A136|bacteria
38229613|expert_4|PD|DDF|change abundance|Akkermansia|bacteria
38229613|expert_4|PD|DDF|change abundance|Dialister|bacteria
38229613|expert_4|Parkinson's disease|DDF|change abundance|Faecalibacterium|bacteria
38229613|expert_4|Parkinson's disease|DDF|change abundance|Roseburia|bacteria
38229613|expert_4|PD cases|human|used by|Full-length bacterial 16S rRNA gene sequencing|biomedical technique
26129950|expert_1|gut microbiota|microbiome|is linked to|liver injuries|DDF
26129950|expert_1|gut microbiota|microbiome|is linked to|cholesterol-related metabolic disorders|DDF
26129950|expert_1|gut microbiota|microbiome|is linked to|liver injury|DDF
26129950|expert_1|gut microbiota|microbiome|is linked to|cholesterol accumulation|DDF
26129950|expert_1|antibiotics|drug|impact|gut microbiota|microbiome
26129950|expert_1|gut microbiota|microbiome|is linked to|metabolic diseases|DDF
26129950|expert_1|cholesterol accumulation|DDF|target|rats|animal
26129950|expert_1|liver injury|DDF|target|rats|animal
26129950|expert_1|gut microbiota|microbiome|located in|rats|animal
32155131|expert_2|Parkinson|DDF|is a|neurodegenerative disorder|DDF
32155131|expert_2|SLAB51|dietary supplement|influence|PD|DDF
32155131|expert_2|abnormalities in the gut function|DDF|affect|Parkinson|DDF
37468912|expert_2|LDSD|DDF|interact|7-ketodeoxycholic acid|chemical
37468912|expert_2|liver depression and spleen deficiency|DDF|affect|diarrhea-predominant irritable bowel syndrome|DDF
37468912|expert_2|LDSD|DDF|interact|serum BA precursor 7α-hydroxy-4-cholesten-3-one|chemical
37468912|expert_2|abdominal pain|DDF|affect|liver depression and spleen deficiency|DDF
37468912|expert_2|Dysregulation of gut microbiota-host bile acid (BA) co-metabolism|DDF|affect|IBS-D|DDF
37468912|expert_2|liver depression|DDF|target|IBS-D patients|human
37468912|expert_2|spleen deficiency pattern|DDF|target|IBS-D patients|human
37468912|expert_2|7-dehydroxylating bacteria|bacteria|part of|LDSD gut microbiota|microbiome
37468912|expert_2|liver depression and spleen deficiency|DDF|change abundance|7-dehydroxylating bacteria|bacteria
37468912|expert_2|Altered gut microbiota-host bile acid metabolism|DDF|target|IBS-D patients|human
37468912|expert_2|gut microbiota|microbiome|is linked to|liver depression and spleen deficiency|DDF
37468912|expert_2|IBS-D|DDF|target|Patients|human
37468912|expert_2|LDSD|DDF|interact|deoxycholic acid|chemical
37468912|expert_2|LDSD|DDF|target|IBS patients|human
37468912|expert_2|LDSD|DDF|target|IBS-D patients|human
37468912|expert_2|LDSD|DDF|affect|IBS-D|DDF
37468912|expert_2|BAs|chemical|influence|liver depression and spleen deficiency|DDF
37468912|expert_2|LDSD|DDF|interact|lithocholic acid|chemical
37468912|expert_2|LDSD|DDF|interact|DCA|chemical
37468912|expert_2|Dysregulation of gut microbiota-host bile acid (BA) co-metabolism|DDF|affect|diarrhea-predominant irritable bowel syndrome|DDF
32987656|expert_6|PD|DDF|affect|bradykinesia|DDF
32987656|expert_6|Polyphenols|chemical|produced by|gut microbiome|microbiome
32987656|expert_6|PD|DDF|affect|neuroinflammatory processes|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|postural instability|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|fatigue|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|tremor at rest|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|impaired sleep|DDF
32987656|expert_6|PD|DDF|affect|olfactory impairment|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|autonomic dysfunction|DDF
32987656|expert_6|PD|DDF|affect|disruption to mitochondria|DDF
32987656|expert_6|PD|DDF|affect|pain|DDF
32987656|expert_6|Polyphenols|chemical|influence|inflammation|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|bradykinesia|DDF
32987656|expert_6|PD|DDF|affect|alterations to the protein α-synuclein|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|rigidity|DDF
32987656|expert_6|Dietary Polyphenols|chemical|influence|Parkinson's Disease|DDF
32987656|expert_6|PD|DDF|affect|non-motor symptoms|DDF
32987656|expert_6|PD|DDF|affect|postural instability|DDF
32987656|expert_6|PD|DDF|affect|oxidative stress|DDF
32987656|expert_6|PD|DDF|affect|fatigue|DDF
32987656|expert_6|PD|DDF|affect|behavioral changes|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|olfactory impairment|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|pain|DDF
32987656|expert_6|PD|DDF|affect|tremor at rest|DDF
32987656|expert_6|PD|DDF|affect|impaired sleep|DDF
32987656|expert_6|PD|DDF|affect|autonomic dysfunction|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|behavioral changes|DDF
32987656|expert_6|Parkinson's disease|DDF|affect|non-motor symptoms|DDF
32987656|expert_6|PD|DDF|affect|rigidity|DDF
36986165|expert_7|inflammation|DDF|affect|central nervous system diseases|DDF
36986165|expert_7|Neurological diseases|DDF|affect|disability|DDF
36986165|expert_7|omega-3 fatty acids|chemical|influence|neurological diseases|DDF
36986165|expert_7|probiotics|dietary supplement|influence|neurological diseases|DDF
36986165|expert_7|inflammatory processes|DDF|affect|neurological diseases|DDF
36986165|expert_7|polyphenols|chemical|influence|neurological diseases|DDF
36986165|expert_7|essential minerals|chemical|influence|neurological diseases|DDF
36986165|expert_7|nuts|food|influence|neurological diseases|DDF
36986165|expert_7|gut microbiome|microbiome|is linked to|neurological diseases|DDF
36986165|expert_7|Inflammatory Process|DDF|affect|Neurological Diseases|DDF
36986165|expert_7|fruits|food|influence|neurological diseases|DDF
36986165|expert_7|herbs|food|influence|neurological diseases|DDF
36986165|expert_7|legumes|food|influence|neurological diseases|DDF
36986165|expert_7|vegetables|food|influence|neurological diseases|DDF
36986165|expert_7|vitamins|chemical|influence|neurological diseases|DDF
36986165|expert_7|spices|food|influence|neurological diseases|DDF
33244049|expert_5|gut microbiome|microbiome|located in|healthy adults|human
33244049|expert_5|healthy Korean adults|human|used by|high-throughput 16S rRNA gene sequencing|biomedical technique
33244049|expert_5|gut microbiota|microbiome|used by|high-throughput 16S rRNA gene sequencing|biomedical technique
33244049|expert_5|gut microbiota|microbiome|located in|healthy Korean adults|human
33244049|expert_5|gut microbiota|microbiome|located in|gut|anatomical location
33651324|expert_4|HIV|DDF|target|persons|human
33651324|expert_4|aerotolerant bacteria|bacteria|located in|PLWH|human
33825149|expert_7|Gut microbial dysbiosis|DDF|affect|mitochondrial dysfunction|DDF
33825149|expert_7|gut microbial metabolites|chemical|influence|PD|DDF
33825149|expert_7|Mitochondrial dysfunction|DDF|affect|Parkinson's Disease|DDF
33825149|expert_7|Mitochondrial Dysfunction|DDF|affect|Parkinson's Disease|DDF
33825149|expert_7|gut microbial dysbiosis|DDF|affect|PD|DDF
33825149|expert_7|Mitochondrial dysfunction|DDF|affect|Parkinson's disease|DDF
33825149|expert_7|gut microbial dysbiosis|DDF|affect|Parkinson's disease|DDF
33825149|expert_7|gut microbiota|microbiome|is linked to|Parkinson's disease|DDF
33825149|expert_7|gut microbiota|microbiome|is linked to|PD|DDF
33825149|expert_7|microbial metabolites|chemical|influence|mitochondrial dysfunction|DDF
33825149|expert_7|Mitochondrial dysfunction|DDF|affect|PD|DDF
33825149|expert_7|gut microbial metabolites|chemical|influence|Parkinson's disease|DDF
33825149|expert_7|microbial metabolites|chemical|influence|PD|DDF
33825149|expert_7|Gut Microbial Metabolites|chemical|influence|Parkinson's Disease|DDF
36881806|expert_2|gut microbiota|microbiome|is linked to|psychiatric disorders|DDF
33899052|expert_5|gut microbiome|microbiome|is linked to|constipation|DDF
33899052|expert_5|PD|DDF|target|individuals|human
33899052|expert_5|Parkinson's disease|DDF|target|men and women over 40 years old|human
33899052|expert_5|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
33899052|expert_5|Anaerotruncus|bacteria|part of|gut microbiome|microbiome
33899052|expert_5|PD|DDF|target|men and women over 40 years old|human
33899052|expert_5|genus Roseburia|bacteria|part of|gut microbiome|microbiome
33899052|expert_5|constipation|DDF|target|individuals|human
33899052|expert_5|individuals|human|used by|OMM-sequence|biomedical technique
33899052|expert_5|constipation|DDF|target|subjects|human
33899052|expert_5|phylum Firmicutes|bacteria|part of|gut microbiome|microbiome
33899052|expert_5|gut microbiome|microbiome|located in|individuals|human
33899052|expert_5|PD|DDF|target|patients|human
33899052|expert_5|men and women over 40 years old|human|used by|OMM-sequence|biomedical technique
33899052|expert_5|constipation|DDF|target|patients|human
33899052|expert_5|phyla Actinobacteria|bacteria|part of|gut microbiome|microbiome
33899052|expert_5|gut microbiome|microbiome|located in|men and women over 40 years old|human
33899052|expert_5|men and women over 40 years old|human|used by|osteopathic manipulative medicine (OMM) sequence|biomedical technique
33899052|expert_5|Verrucomicrobia|bacteria|part of|gut microbiome|microbiome
33899052|expert_5|chronic constipation|DDF|target|men and women over 40 years old|human
33899052|expert_5|gut microbiome|microbiome|is linked to|PD|DDF
33899052|expert_5|Intestinimonas|bacteria|part of|gut microbiome|microbiome
32772900|expert_5|Gut Microbiome|microbiome|is linked to|anxiety|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|behavioural and psychological symptoms of dementia|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|BPSD|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|mental health and neurocognitive disorders|DDF
32772900|expert_5|post-traumatic stress disorder|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|depression|DDF
32772900|expert_5|depression|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|PTSD|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|mental health and neurocognitive disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|anxiety|DDF
32772900|expert_5|GM|microbiome|is linked to|OCD|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|PTSD|DDF
32772900|expert_5|psychotropics|drug|impact|gut microbiota|microbiome
32772900|expert_5|bipolar disorder|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|Gut microbes|microbiome|located in|individuals|human
32772900|expert_5|Gut Microbiome|microbiome|is linked to|schizophrenia|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|OCD|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|BP|DDF
32772900|expert_5|GM|microbiome|is linked to|depression|DDF
32772900|expert_5|neurocognitive and mental health disorders|DDF|target|individuals|human
32772900|expert_5|GM|microbiome|is linked to|behavioural and psychological symptoms of dementia|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|depression|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|post-traumatic stress disorder|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|BPSD|DDF
32772900|expert_5|schizophrenia|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|dementia|DDF
32772900|expert_5|psychotropics|drug|impact|GM|microbiome
32772900|expert_5|GM|microbiome|is linked to|PTSD|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|behavioural and psychological symptoms of dementia|DDF
32772900|expert_5|psychotropics|drug|change effect|neurocognitive and mental health disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|schizophrenia|DDF
32772900|expert_5|obsessive-compulsive disorder|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|dementia|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|BPSD|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|schizophrenia|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|post-traumatic stress disorder|DDF
32772900|expert_5|GM|microbiome|is linked to|BP|DDF
32772900|expert_5|probiotics|dietary supplement|influence|neurocognitive and mental health disorders|DDF
32772900|expert_5|psychotropic medications|drug|impact|gut microbiota|microbiome
32772900|expert_5|Gut Microbiome|microbiome|is linked to|bipolar disorder|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|BP|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|obsessive-compulsive disorder|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|dementia|DDF
32772900|expert_5|BP|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|PTSD|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|microbial dysbiosis|DDF
32772900|expert_5|OCD|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|Gut Microbiome|microbiome|located in|individuals|human
32772900|expert_5|gut microbiota|microbiome|is linked to|Gut dysbiosis|DDF
32772900|expert_5|psychotropic medications|drug|impact|GM|microbiome
32772900|expert_5|gut microbiota|microbiome|is linked to|neurocognitive and mental health disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|dementia|DDF
32772900|expert_5|GM|microbiome|is linked to|obsessive-compulsive disorder|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|obsessive-compulsive disorder|DDF
32772900|expert_5|anxiety|DDF|is a|mental health and neurocognitive disorders|DDF
32772900|expert_5|microbial dysbiosis|DDF|affect|bipolar disorder|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|mental health and neurocognitive disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|post-traumatic stress disorder|DDF
32772900|expert_5|Gut Microbiome|microbiome|is linked to|OCD|DDF
32772900|expert_5|GM|microbiome|located in|individuals|human
32772900|expert_5|GM|microbiome|is linked to|bipolar disorder|DDF
32772900|expert_5|Gut microbes|microbiome|is linked to|neurocognitive and mental health disorders|DDF
32772900|expert_5|GM|microbiome|is linked to|microbial dysbiosis|DDF
27900676|expert_1|gut microbiota|microbiome|located in|schizophrenia patients|human
27900676|expert_1|Chronic low-grade inflammation|DDF|affect|schizophrenia|DDF
27900676|expert_1|cytokines|chemical|influence|schizophrenia|DDF
27900676|expert_1|schizophrenia|DDF|target|patients|human
26190966|expert_4|obesity|DDF|affect|peripheral low-grade inflammation|DDF
26190966|expert_4|Obesity|DDF|affect|mood disorders|DDF
26190966|expert_4|Obesity|DDF|affect|type 2 diabetes|DDF
26190966|expert_4|obesity|DDF|affect|neuroinflammation|DDF
26190966|expert_4|dysfunction|DDF|strike|vulnerable brain regions|anatomical location
26190966|expert_4|Obesity|DDF|affect|cardiovascular diseases|DDF
26190966|expert_4|Obesity|DDF|affect|cognitive dysfunctions|DDF
35722294|expert_7|Parkinson's Disease|DDF|change abundance|Blautia|bacteria
35722294|expert_7|Parkinson's disease|DDF|target|PD patients|human
35722294|expert_7|Blautia|bacteria|located in|PD patients|human
35722294|expert_7|brain|anatomical location|located in|PD patients|human
35722294|expert_7|gut microbiome|microbiome|is linked to|PD|DDF
35722294|expert_7|gut microbiome|microbiome|is linked to|Parkinson's disease|DDF
35722294|expert_7|PD|DDF|target|PD patients|human
35722294|expert_7|PD|DDF|change abundance|Blautia|bacteria
38260914|expert_4|rosacea|DDF|target|patients|human
34032650|expert_7|fermented foods|food|administered|patients|human
34032650|expert_7|grains|food|administered|patients|human
34032650|expert_7|psychobiotics|bacteria|located in|healthy populations|human
34032650|expert_7|Psychobiotics|bacteria|interact|Antidepressants|drug
34032650|expert_7|psychobiotics|bacteria|influence|depression|DDF
34032650|expert_7|gut microbiota|microbiome|is linked to|depression|DDF
34032650|expert_7|psychobiotics|bacteria|located in|patients|human
34032650|expert_7|fish|food|administered|patients|human
34032650|expert_7|fibres|food|administered|patients|human
34032650|expert_7|major depression|DDF|target|patients|human
34032650|expert_7|depression|DDF|target|patients|human
34277527|expert_7|gut microbiota|microbiome|located in|Brain|anatomical location
34277527|expert_7|gut microbiota alterations|DDF|affect|NDDs|DDF
34277527|expert_7|gut microbiota alterations|DDF|affect|neurodevelopmental disorders|DDF
34277527|expert_7|nutritional deficiencies|DDF|affect|neurodevelopmental disorders|DDF
34277527|expert_7|nutritional deficiencies|DDF|affect|NDDs|DDF
36216056|expert_4|Fibrobacteres|bacteria|interact|phosphocholine|chemical
36216056|expert_4|phosphocholine|chemical|influence|anxiety|DDF
36216056|expert_4|Verrucomicrobia|bacteria|interact|estriol|chemical
36216056|expert_4|PM|chemical|impact|Fibrobacteres|bacteria
36216056|expert_4|particulate matter|chemical|influence|SCZ|DDF
36216056|expert_4|PM|chemical|influence|schizophrenia|DDF
36216056|expert_4|particulate matter|chemical|influence|schizophrenia|DDF
36216056|expert_4|PM|chemical|impact|Verrucomicrobia|bacteria
36216056|expert_4|Deinococcus-Thermus|bacteria|interact|phosphocholine|chemical
36216056|expert_4|PM|chemical|influence|SCZ|DDF
37834373|expert_4|microbial community|microbiome|is linked to|Alzheimer's disease|DDF
37834373|expert_4|microbial community|microbiome|is linked to|Parkinson's disease|DDF
34002020|expert_4|endocannabinoid palmitoylethanolamide|chemical|influence|anhedonia/amotivation|DDF
34002020|expert_4|PEA|chemical|influence|anhedonia/amotivation|DDF
31704402|expert_4|gut microbiome|microbiome|located in|mice|animal
31704402|expert_4|Kineothrix alysoides|bacteria|located in|high biodiversity treatment mice|animal
31704402|expert_4|Kineothrix alysoides|bacteria|influence|anxiety-like behaviour|DDF
31704402|expert_4|anxiety-like behaviour|DDF|target|anxious mice|animal
35327401|expert_7|gut microbiota|microbiome|located in|Drosophila melanogaster|animal
35327401|expert_7|Gut Microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
35327401|expert_7|mammalian gut microbiome|microbiome|located in|mammals|animal
35327401|expert_7|gut microbiota|microbiome|is linked to|neurodegenerative diseases|DDF
35327401|expert_7|gut microbiota|microbiome|located in|fruit fly|animal
35327401|expert_7|gut microbiota|microbiome|is linked to|Neurodegenerative Diseases|DDF
35327401|expert_7|gut microbiota|microbiome|located in|Drosophila|animal
34520319|expert_3|gut microbiota|microbiome|is linked to|mild cognitive impairment|DDF
34520319|expert_3|gut microbiota|microbiome|is linked to|Alzheimer's disease|DDF
34520319|expert_3|sleep and circadian rhythm disruption|DDF|interact|Aβ|chemical
34520319|expert_3|SCRD|DDF|interact|β-amyloid|chemical
34520319|expert_3|SCRD|DDF|interact|Aβ|chemical
34520319|expert_3|sleep and circadian rhythm disruption|DDF|interact|β-amyloid|chemical
34520319|expert_3|GM|microbiome|is linked to|AD|DDF
34520319|expert_3|GM|microbiome|is linked to|mild cognitive impairment|DDF
34520319|expert_3|gut microbiota|microbiome|is linked to|AD|DDF
34520319|expert_3|impaired sleep and circadian patterns|DDF|affect|AD|DDF
34520319|expert_3|GM|microbiome|is linked to|MCI|DDF
34520319|expert_3|GM|microbiome|is linked to|SCRD|DDF
34520319|expert_3|gut microbiota|microbiome|is linked to|MCI|DDF
34520319|expert_3|GM|microbiome|is linked to|Alzheimer's disease|DDF
